Document:

EX-10.2

 Exhibit 10.2 

EMPLOYMENT AGREEMENT 

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between LIFETIME BRANDS, INC. (the
“Company”) and ROBERT B. KAY (the “Executive”) as of December 22, 2017. 
 WHEREAS, the Company
desires to employ the Executive as its Chief Executive Officer and the Executive desires to serve in such capacity on behalf of the Company. 

NOW, THEREFORE, in consideration of the premises and of the mutual covenants and agreements hereinafter set forth, the Company and the
Executive hereby agree as follows: 
  

	 	1.	Employment. 

 (a)    Term. The Executive’s term of
employment under this Agreement shall begin on the closing of the transactions contemplated by that certain Agreement and Plan of Merger dated December 21, 2017 by and among Lifetime Brands, Inc., Taylor Parent, LLC, Taylor Holdco, LLC and
certain other parties thereto (such agreement, the “Merger Agreement”, and such date, the “Effective Date”), and shall continue until the third anniversary of the Effective Date, and shall automatically renew for
consecutive one year periods, unless (i) either party gives the other party written notice (“Notice of Non-Renewal”) at least 180 days prior to the end of the initial term or any one-year renewal period that the term of the Agreement shall not be further extended or (ii) sooner terminated by either party as set forth below. The Executive’s period of employment under this Agreement
is referred to herein as the “Term.” 
 (b)    Duties. During the Term, the Executive shall
serve as the Chief Executive Officer of the Company with duties, responsibilities and authority commensurate therewith and shall report to the Board of Directors of the Company (the “Board”). The Executive shall perform all duties
and accept all responsibilities incident to such position as may be reasonably assigned to the Executive by the Board. The Executive represents to the Company that the Executive is not subject to or a party to any employment agreement, non-competition covenant, or other agreement that would be breached by, or prohibit the Executive from executing, this Agreement and performing fully the Executive’s duties and responsibilities hereunder. The
Executive shall take all actions necessary to terminate any direct or indirect employment, consulting, or other services agreement between (i) the Executive or any of his affiliates (including without limitation Robert Kay Management LLC) and
(ii) Taylor Parent LLC, Centre Partners Management LLC, or any of their respective affiliates, so that no such agreement shall be in effect as of the Effective Date or at any time during the Term. 

(c)    No Other Employment. During the Term, the Executive shall not, directly or indirectly, render services to
any other person or organization for which he receives compensation; provided, however, that upon the receipt of the Board’s prior written approval to be granted in its sole discretion, which approval shall not unreasonably be withheld, the
Executive may accept an election to the board of directors of no more than two other companies, only one of which may be a publicly traded company; provided further that, such activities do not otherwise conflict with Executive’s duties and
obligations to the Company. The Company acknowledges that (i) the Executive serves on the board of directors of Nearly Naturals LLC, (ii) 

 
such board service shall not be included for purposes of calculating the limitation on board membership set forth in the preceding sentence, and (iii) the Board hereby consents to such board
service; provided that it does not otherwise conflict with the Executive’s obligations and duties to the Company. Board approval will not be required if the Executive seeks to perform services without direct compensation therefor in connection
with the management of personal or family investments or in connection with the performance of charitable and civic activities, provided that such activities do not contravene the provisions of Section 11. 

(d)    Board Membership, etc. The Executive shall be appointed to the Board as of the Effective Date. With respect
to each applicable election thereafter during the Term, the Nominating Committee of the Board shall nominate the Executive for re-election to the Board. 

(e)    Principal Place of Employment. The Executive’s principal office location shall be at the Company’s
office in Garden City, New York; provided, however, that the Executive recognizes that frequent travel, both within and outside the United States, shall be required in connection with his responsibilities under this Agreement. 

2.    Compensation. 

(a)    Base Salary. During the Term, the Company shall pay the Executive a base salary (“Base
Salary”) at the annual rate of $800,000. Base Salary shall be paid in installments in accordance with the Company’s normal payroll practices. 

(b)    Annual Bonuses. For each year during the Term commencing with the year ending December 31, 2018, the
Executive shall receive an “Annual Adjusted IBIT Performance Bonus” and an “Annual Individual Goal Bonus” determined as follows: 

(i)    Annual Adjusted IBIT Performance Bonus. The Compensation Committee of the Board (the
“Compensation Committee”) shall prepare and deliver to the Executive within 90 days following the beginning of each year during the Term commencing with the year ending December 31, 2018 an Adjusted IBIT Performance Bonus Table
(the “Adjusted IBIT Performance Bonus Table”) for such year under which (A) the Adjusted IBIT (as defined in Section 9(a)) to be achieved by the Company for the Executive to obtain 100% of the Adjusted IBIT Target Bonus
shall be based on the annual budget for such year prepared by the management of the Company and approved by the Board and (B) the “Adjusted IBIT Target Bonus” shall be 87.5% of the Base Salary payable to the Executive for such
year. The threshold Adjusted IBIT for such year shall be 50% of the target Adjusted IBIT for such year which, if achieved, would entitle the Executive to receive 50% of the Adjusted IBIT Target Bonus for such year consistent with the Adjusted IBIT
Performance Bonus Table for such year. The maximum Adjusted IBIT for such year shall be 200% of the target Adjusted IBIT for such year which, if achieved, would entitle the Executive to receive 200% of the Adjusted IBIT Target Bonus for such year,
consistent with the Adjusted IBIT Performance Bonus Table for such year. The Executive shall be entitled to receive the sliding scale percentages of the Adjusted IBIT Target Bonus set forth in the Adjusted IBIT Performance Bonus Table based upon
Adjusted IBIT being more than the threshold Adjusted IBIT but less than the target Adjusted IBIT, or more than the target Adjusted IBIT but less than the maximum 

  
 2 

 
Adjusted IBIT; provided, however, that notwithstanding anything to the contrary contained in this Agreement, the Annual Adjusted IBIT Performance Bonus for any such year shall be zero if the
Adjusted IBIT achieved by the Company for such year is less than the threshold Adjusted IBIT for such year, and in no event shall an Annual Adjusted IBIT Performance Bonus for any such year be more than 200% of the Adjusted IBIT Target Bonus for
such year even if the Adjusted IBIT achieved by the Company for such year exceeds the maximum Adjusted IBIT for such year. The Company shall pay the Annual Adjusted IBIT Performance Bonus earned by the Executive for each year in the immediately
following year, no later than March 15. Any bonuses payable by the Company to the Executive pursuant to this Section 2(b)(i) shall be awarded under and subject to the terms of the Company’s 2000 Incentive Bonus Compensation Plan, as
amended from time to time (the “Bonus Plan”), subject to any approval of shareholders of the Company, if required by Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”). 

(ii)    Annual Individual Goal Bonuses. For each year during the Term commencing with the year
ending December 31, 2018, the Executive shall be eligible to receive an Annual Individual Goal Bonus equal to 25% of his Base Salary for such year (“Individual Goal Target Bonus”) based on meeting individual measurable
objectives set by the Compensation Committee in consultation with the Executive, as determined by the Compensation Committee in its sole discretion; provided, however, that if, in the sole discretion of the Compensation Committee, (A) the
Executive meets at least 50% of such objectives, he shall be entitled to an Annual Individual Goal Bonus equal to not less than 50% of the Individual Goal Target Bonus and (B) the Executive meets less than 50% of such objectives, he shall not
be entitled to receive any Annual Individual Goal Bonus for such year. The Annual Individual Goal Bonus will be paid at the same time as the Annual Adjusted IBIT Performance Bonus. 

(iii)    2018 Annual Bonus. In the event that the Effective Date occurs after April 1, 2018,
any Annual Adjusted IBIT Performance Bonus and any Annual Individual Goal Bonus payable to the Executive for 2018 shall be pro-rated, based on the Executive’s period of employment by the Company during
2018. 
 (c)    Equity Incentive Awards. As soon as practicable following the Effective Date, the Company shall: 

(i)    Grant to the Executive 50,000 restricted shares of the Company’s Common Stock pursuant to the
Company’s 2000 Long-Term Incentive Plan, as it may be amended from time to time (“Equity Plan”). The restrictions on such 50,000 restricted shares shall lapse in equal installments on each of the first, second, and third
anniversaries of the Effective Date, subject to the terms and conditions of the Equity Plan, including any minimum vesting requirements. 

(ii)    Grant to the Executive 50,000 performance-based deferred stock units pursuant to the Equity Plan,
which shall be subject to the terms and conditions established by the Compensation Committee and the terms and conditions of the Equity Plan. The performance goals and other vesting terms applicable to such deferred stock units shall be no less
favorable than those granted to other named executive officers in respect of the performance period commencing in 2018. 

  
 3 

 (iii)    Grant to the Executive options
(“Options”) to purchase 150,000 shares of the Company’s Common Stock pursuant to the Equity Plan, at an exercise price per share equal to the closing price of a share of the Company’s Common Stock on the date of grant,
which shall be within three business days following the Effective Date. The Options shall vest in equal installments on each first, second, and third anniversaries of the Effective Date, subject to the terms and conditions of the Equity Plan,
including any minimum vesting requirements. The Options shall be granted as incentive stock options, to the maximum extent permitted by the Code, and any Options which are not granted as incentive stock options shall be granted as nonqualified stock
options. 
 (d)    Automobile Allowance. During the Term, the Company shall pay the Executive an automobile
allowance of up to $1,500 per month. This automobile allowance is intended to cover all expenses associated with the Executive’s use of an automobile for Company business, so that no other expenses relating to such automobile use will be
reimbursed, except gas and tolls incurred in using such automobile for Company business. 
 3.    Certain Additional
Expenses. 
 (a)    Upon submission of proper documentation, the Company will pay or reimburse the Executive for all
travel expenses incurred by the Executive on business trips taken outside the metropolitan New York area and for all other business and entertainment expenses reasonably incurred by him in connection with activities relating to the business of the
Company and its subsidiaries during the Term, all in accordance with Company policies then in effect. Such expenses shall include first class travel expenses for travel that is scheduled to take more than four hours, incurred or expended by the
Executive incident to the performance of his duties hereunder. In addition, the Executive is entitled to receive reimbursement for all reasonable and necessary travel expenses incurred by the Executive’s spouse or significant other with respect
to the attendance at the annual meeting of the Internal Housewares Association. 
 (b)    The Company shall promptly
reimburse the Executive, upon submission of appropriate documentation in accordance with the policies and procedures of the Company as in effect from time to time, or pay directly upon submission by the Executive to the Company of statements, up to
a total of $35,000 during any calendar year during the Term beginning with the calendar year 2018, for services paid or payable, as the case may be, by the Executive, for services rendered by any person or persons of the Executive’s choice that
the Executive retains to advise the Executive with regard to legal, financial, investment and/or tax advice, and the drafting of wills and trusts in connection with estate planning. The Executive acknowledges that the benefits provided under this
paragraph shall constitute taxable income to the Executive, and the Executive shall be solely responsible for the payment of all federal, state and local taxes imposed upon the Executive in relation thereto. 

4.    Benefit and Compensation Plans. During the Term, the Executive shall be eligible to participate in the
Company’s medical and disability plans and programs, as well as any pension, profit-sharing, bonus, stock award, stock option or similar plan, in each case as may 

  
 4 

 
be available to senior executives of the Company from time to time, pursuant to their respective terms and conditions. In addition, if obtainable and structured for tax purposes similar to the
long-term disability plan in effect for the Company’s senior executives, if any, the Company shall also provide the Executive with long term disability insurance pursuant to the Company’s group disability policy, in an amount sufficient to
pay the Executive an additional $15,000 per month until the otherwise applicable expiration date of the Agreement, in the event the Executive’s employment is terminated on account of long-term disability. Nothing in this Agreement shall
preclude the Company or any affiliate of the Company from terminating or amending any employee benefit plan or program from time to time after the Effective Date. 

5.    Vacation. During each year of the Term, the Executive shall be entitled to 30 days of paid vacation (pro-rated for any partial years) and holiday and sick leave at levels commensurate with those provided to other senior executives of the Company, in accordance with the Company’s vacation, holiday and other
pay for time not worked policies. The Executive shall have the right to carry over to a subsequent period or periods any vacation days unused by him up to a maximum of 30 days at any time; provided that, for the avoidance of doubt, at no time shall
the Executive be entitled to accrued vacation in excess of 60 days in any calendar year. 
 6.    Termination.
Upon termination of the Executive’s employment pursuant to this Section 6, however caused, the Executive shall be entitled to no other payments, compensation, severance or benefits except as expressly stated in this Section 6. 

(a)    Termination by the Company without Cause; Termination by Executive for Good Reason. The Company may
terminate the Executive’s employment without Cause at any time upon written notice, or the Executive may terminate his employment with the Company for Good Reason. If the Executive’s employment is terminated by the Company without Cause or
the Executive terminates his employment with the Company for Good Reason and Section 6(c)(i) does not apply, then subject to Section 6(i), the Executive shall be entitled to receive the following: 

(i)    an amount equal to two times the Executive’s annual Base Salary as in effect on the termination
date, payable in installments over the 24 month period following the termination date in accordance with the Company’s normal payroll practices (but no less frequently than monthly); 

(ii)    the Pro-Rated Performance Bonus (as defined in
Section 9(e)) for the fiscal year in which the effective date of the termination occurs, payable at the same time as the Annual Adjusted IBIT Performance Bonus for such fiscal year would otherwise have been paid; 

(iii)    an amount equal to two times the Target Bonus (as defined in Section 9(g)), payable within 60
days following the termination date; 
 (iv)    if the Executive timely and properly elects COBRA
continuation coverage for medical and dental benefits and remains eligible for such coverage during the 12-month period following the Executive’s termination date, then during such 12-month 

  
 5 

 
period, such coverage shall be provided to the Executive at the then-applicable active employee rates; provided that, the portion of COBRA premiums paid by the Company shall be reported as income
to the Executive, to the extent consistent with applicable law; and 
 (v)    accelerated vesting of all
of the Executive’s then outstanding stock options and the lapse of all restrictions on shares of restricted stock granted by the Company to the Executive, subject to the terms of the Equity Plan and any applicable grant agreement. 

(b)    Termination Due to Expiration or Non-Renewal of the Term. In the
event that the Executive’s employment terminates upon expiration of the Term following the Company’s delivery of a Notice of Non-Renewal and Section 6(c)(i) does not apply, then subject to
Section 6(i), the Executive shall be entitled to receive the following: 
 (i)    an amount equal to
the Executive’s annual Base Salary as in effect upon the expiration of the Term, payable in installments over the 12 month period following the termination date in accordance with the Company’s normal payroll practices (but no less
frequently than monthly); 
 (ii)    the Annual Adjusted IBIT Performance Bonus for the fiscal year in
which the effective date of the termination occurs, payable at the same time as the Annual Adjusted IBIT Performance Bonus for such fiscal year would otherwise have been paid; 

(iii)    if the Executive timely and properly elects COBRA continuation coverage for medical and dental
benefits and remains eligible for such coverage during the 12-month period following the Executive’s termination date, then during such 12-month period, such
coverage shall be provided to the Executive at the then-applicable active employee rates; provided that, the portion of COBRA premiums paid by the Company shall be reported as income to the Executive, to the extent consistent with applicable law;
and 
 (iv)    accelerated vesting of all of the Executive’s then outstanding stock options and the
lapse of all restrictions on shares of restricted stock granted by the Company to the Executive, subject to the terms of the Equity Plan and any applicable grant agreement. 

(c)    Termination in connection with a Change of Control. 

(i)    In the event that the Executive’s employment is terminated by the Company without Cause, by the
Executive for Good Reason, or upon expiration of the Term following the delivery of a Notice of Non-Renewal by the Company, in each case upon or within two years following a Change of Control (as defined in
Section 9(c)), then subject to Section 6(i), the Executive shall be entitled to receive the following: 

(A)    a cash payment equal to two times the Executive’s annual Base Salary as in effect on the
effective date of the Change of Control, or if greater, two times the Executive’s annual Base Salary in effect on the date of termination, payable in a lump sum within 60 days following the employment termination date; 

  
 6 

 (B)    the Pro-Rated
Performance Bonus for the fiscal year in which the effective date of the termination occurs, payable at the same time as the Annual Adjusted IBIT Performance Bonus for such fiscal year would otherwise have been paid; 

(C)    two times the Target Bonus, payable within 60 days following the termination date; 

(D)    if the Executive timely and properly elects COBRA continuation coverage for medical and dental
benefits and remains eligible for such coverage during the 12-month period following the Executive’s termination date, then during such 12-month period, such
coverage shall be provided to the Executive at the then-applicable active employee rates; provided that, the portion of COBRA premiums paid by the Company shall be reported as income to the Executive, to the extent consistent with applicable law;
and 
 (E)    accelerated vesting of all of the Executive’s then outstanding stock options and the
lapse of all restrictions on shares of restricted stock granted by the Company to the Executive, subject to the terms of the Equity Plan and any applicable grant agreement. 

For the avoidance of doubt, in the event that the Executive’s employment is terminated in accordance with this Section 6(c)(i), the
Executive shall only be entitled to termination payments and benefits as provided under this Section 6(c)(i) and shall not be entitled to any other termination payments or benefits under any other section of this Agreement (other than any
payments or benefits to which the Executive may be entitled under Section 6(h)). 
 (ii)    In the
event that the Executive’s employment is terminated by the Company without Cause, by the Executive for Good Reason, or upon expiration of the Term following delivery of a Notice of Non-Renewal by the
Company, and in each case, within 90 days following such termination a Change of Control occurs, then within 60 days following the Change of Control, the Executive shall be entitled to receive (A) a lump sum cash payment equal to the excess of
the amount set forth in Section 6(c)(i)(A) less the amount previously paid to the Executive pursuant to Section 6(a)(i) or Section 6(b)(i), as applicable, and (B) in the event that termination is on account of the Company’s
delivery of a Notice of Non-Renewal, the Executive shall be entitled to receive the amount set forth in Section 6(c)(i)(C) within 60 days following the Change of Control. 

(iii)    Notwithstanding the foregoing, if and to the extent required by Section 409A of the Code, if
a Change of Control does not constitute a “change in control event” as defined by Section 409A of the Code or the lump sum payment in Section 6(c)(i)(A) or Section 6(c)(ii)(A) would otherwise cause the Executive to incur
penalties under Section 409A of the Code, such payment shall not be paid in a lump sum but shall be paid (or, in the case of Section 6(c)(ii)(A), continue to be paid) in equal installments in accordance with the payroll practices over the
two year period following Executive’s termination date. 

  
 7 

 (d)    Termination by Company for Cause. The Company may terminate the
Executive’s employment for Cause at any time upon written notice to the Executive, in which event all payments under this Agreement shall cease, except for any amounts to which the Executive may be entitled under Section 6(h). 

(e)    Voluntary Resignation by Executive without Good Reason. The Executive may voluntarily terminate employment
without Good Reason for any reason upon 30 days prior written notice to the Company; provided that, the Company may waive all or any portion of such notice period without the obligation to provide compensation in respect of any waived portion of the
notice period. In such event, after the effective date of such termination, no payments shall be due under this Agreement, except for any payments or benefits to which the Executive may be entitled under Section 6(h). 

(f)    Termination Upon Death of Executive. If the Executive dies during the Term, the Executive’s employment
shall terminate on the date of death and the Company shall pay to the Executive’s executor, legal representative, administrator or designated beneficiary, as applicable, any amounts payable to the Executive under Section 6(h) and any Pro-Rated Performance Bonus accrued through the effective date of his termination of employment to which the Executive may be entitled. Otherwise, the Company shall have no further liability or obligation under this
Agreement to the Executive’s executors, legal representatives, administrators, heirs or assigns or any other person claiming under or through the Executive. 

(g)    Termination Upon Total Disability of Executive. If the Executive incurs a Total Disability (as
defined in Section 9(h)) during the Term, the Company may terminate the Executive’s employment on or after the date of Total Disability. In the event that the Executive’s employment is terminated due to a Total Disability, then
subject to Section 6(i), the Executive shall receive (A) continued payments of the Executive’s Base Salary as then in effect for a period of six months following the effective date of termination, payable in installments in accordance
with the Company’s normal payroll practices (but no less frequently than monthly), provided that payment shall instead be made in a lump sum within 60 days following the termination date, to the extent termination occurs within two years
following a Change of Control which constitutes a “change in control event” under Section 409A of the Code (or, in the event that termination occurs within 90 days prior to a Change of Control which constitutes a “change in
control event” under Section 409A of the Code, any remaining installments shall be paid in a lump sum within 60 days following the Change of Control), and (B) any Pro-Rated Performance Bonus
accrued through the effective date of termination to which the Executive may be entitled. In addition, the Executive shall be entitled to receive any amounts payable to him under Section 6(h). 

(h)    Accrued Obligations. In the event of any termination of employment under this Section 6, the Company
shall pay to the Executive (i) the amount of any accrued but unpaid Base Salary and accrued and unused vacation, less applicable withholdings and deductions, through the date of termination, (ii) reimbursement of expenses or allowances in
accordance with Section 3(a) and not previously reimbursed through the date of termination and (iii) all benefits that are accrued and vested through the date of termination under all employee benefit plans of the Company in which the
Executive was a participant immediately prior to such termination, regardless of whether the Executive executes or revokes the Release (as defined in Section 9(f)). 

  
 8 

 (i)    Release. Notwithstanding anything in this Section 6 to the
contrary, in no event shall the Executive be entitled to receive any amounts, rights or benefits under Section 6(a), (b), (c) or (g) unless the Executive executes, delivers and, if applicable, does not revoke within any applicable
revocation period, a Release and the Release shall have become effective by its terms prior to the 60th day following the Executive’s termination date. Accordingly, payments under Section 6(a), (b), (c) or (g) shall be paid or
commence within 60 days following the Executive’s termination date and following the effective date of the Release; provided that, any installments that would have otherwise been paid in accordance with payroll practices between the termination
date and the date of the first payment shall be paid with the first payment. 
 7.    No Mitigation; No Offset.
In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement and such amounts shall not be reduced,
regardless of whether the Executive obtains other employment. The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any circumstances, including,
without limitation, any set-off, counterclaim, recoupment, defense or other right which the Company may have against the Executive or others. 

8.    Resignation of Positions. Effective as of the date of any termination of employment, the Executive will
resign all Company-related positions, including as an officer and director of the Company and its parents, subsidiaries and affiliates. 

9.    Definitions. For purposes of this Agreement, the following terms shall have the meanings set forth below:

 (a)    “Adjusted IBIT”, as it applies to any particular year, means that amount for such year equal
to the Company’s Income Before Income Taxes, as determined by the Company’s independent auditors, using generally accepted accounting principles, and reported in the Company’s Consolidated Statements of Operations in its Annual Report
on Form 10-K for such year filed with the Securities and Exchange Commission, subject to such adjustments as are set forth in the Adjusted IBIT Performance Bonus Table for such year (which adjustments, shall
be no less favorable than those applied to the bonus arrangements with the other named executive officers of the Company). 

(b)    “Cause” means that the Executive has (i) committed any act of willful misconduct, including
fraud, in connection with his employment by the Company; (ii) materially breached any provision of this Agreement, which breach has not been cured within ten business days after receiving written notice of such breach; (iii) failed,
refused or neglected, other than by reason of a Total Disability, to timely perform any material duty or obligation under this Agreement or to comply with any lawful directive of the Board, which failure, refusal or neglect has not been cured within
ten business days after receiving written notice thereof; (iv) violated any material written policy of the Company, including without limitation, the Company’s nondiscrimination and harassment policy, as determined by a committee of
independent directors of the Board in good faith after reasonable investigation; (v) been formally indicted for a crime involving moral turpitude, dishonesty, fraud or unethical business conduct; (vi) violated a fiduciary obligation to the
Company; (vii) been determined by a governmental body or other 

  
 9 

 
appropriate authority to have violated any material law or regulation that is applicable to the Company’s businesses, or entered into a consent order concerning a violation of any material
law or regulation that is applicable to the Company’s businesses; or (viii) become the subject of an SEC action or administrative proceeding which has been commenced against him. Upon a cure of the acts set forth in subsections
(ii) or (iii) by the Executive within the ten business day cure period to the reasonable satisfaction of the Board, such event shall no longer constitute Cause for purposes of this Agreement. 

(c)    “Change of Control” means (A) the consummation of a merger or consolidation of the Company
with or into another entity or any other corporate reorganization, if more than 50% of the combined voting power of the continuing or surviving entity’s issued shares or securities outstanding immediately after such merger, consolidation or
other reorganization is owned by persons who were not shareholders of the Company 180 days prior to such merger, consolidation or other reorganization; (B) the sale, transfer or other disposition of all or substantially all of the
Company’s assets; (C) a change in the composition of the Board, as a result of which fewer than 50% of the incumbent directors are directors who had been directors of the Company on the date 24 months prior to the date of the event that
may constitute a Change of Control (for example, if the current Board has ten directors, a change of six directors shall constitute a Change of Control); (D) any transaction as a result of which any person is the “beneficial owner” (as
defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), directly or indirectly, of securities of the Company representing at least 50% of the total
voting power represented by the Company then outstanding voting securities (e.g., issued shares). The term “person” shall have the same meaning as when used in sections 13(d) and 14(d) of the Exchange Act but shall exclude (i) a
trustee or other fiduciary holding securities under an employee benefit plan of the Company or of any subsidiary of the Company and (ii) a company owned directly or indirectly by the stockholders of the Company in substantially the same
proportions as their ownership of the ordinary shares of the Company. For the avoidance of doubt, the transactions contemplated by the Merger Agreement shall not constitute a “Change of Control” for purposes of this Agreement. 

(d)    “Good Reason” means the occurrence of any of the following without the Executive’s prior
written consent: (i) a material diminution in the Executive’s duties, or the assignment to the Executive of duties materially inconsistent with the authority, responsibilities and reporting requirements as set forth in Section 1(b);
(ii) the failure of the Board to elect the Executive to the office of Chief Executive Officer of the Company; (iii) the Company, the Board or any person controlling the Company requires the Executive to relocate his principal place of
employment to a location outside of a 50 mile radius from its current location pursuant to Section 1(e), over the objection of the Executive unless such relocation is as the result of exigent circumstances as determined by the Board;
(iv) the failure of the Company to obtain the assumption in writing of its obligations to perform this Agreement by any successor to all or substantially all of the business or assets of the Company not later than the effective date of such
transaction; (v) a material breach by the Company of its obligations under this Agreement; or (vi) the failure of the Board or a Nominating Committee thereof to nominate the Executive for election to the Board. In the event that the
Executive elects to terminate his employment for Good Reason, the Executive shall notify the Company in writing of the grounds for such termination within 30 days of the commencement of such condition and the Company shall have 30 days from the
receipt of such notice to cure such condition. The Executive must terminate his employment within the 90-day period following the initial existence of the circumstances constituting Good Reason. 

  
 10 

 (e)    “Pro-Rated Performance
Bonus” for a particular fiscal year means the amount equal to the Annual Adjusted IBIT Performance Bonus for such fiscal year that would have been payable to the Executive by the Company for such fiscal year, as determined by the Board, if
this Agreement had not been terminated during such fiscal year times a fraction, the numerator of which is the number of months elapsed during such fiscal year up to and including the month in which the termination of the Term occurs and the
denominator of which is 12. 
 (f)    “Release” means a release of claims against the Company in the
form attached hereto as Exhibit A, subject to any legally required changes. 
 (g)    “Target
Bonus” means 112.5% of the Executive’s annual Base Salary in effect at the time of termination; provided that, for purposes of Section 6(c), Target Bonus means 112.5% of the greater of (i) the Executive’s annual Base
Salary in effect at the time of termination or (ii) the Executive’s annual Base Salary in effect at the effective date of the Change of Control. 

(h)    “Total Disability” means the failure of the Executive, after reasonable accommodation, to perform
his duties for an aggregate period of 120 consecutive days during any 12 month period by reason of the Executive’s physical or mental disability. The Company’s obligation to pay the Base Salary to the Executive during such 120 consecutive
day period shall be conditioned upon the Executive complying with all requirements under the Company’s short-term and long-term disability insurance policies, as determined in the sole discretion of the short-term and long-term disability
insurance providers. Notwithstanding the foregoing, in the event that the short-term and/or long-term insurance providers pay to the Executive any amounts required to be paid by such insurance providers under the Company’s short-term and/or
long-term disability insurance policies, as applicable, for the 120 consecutive day period prior to the termination of the Executive’s employment due to Total Disability pursuant to Section 6(g), then during such 120 consecutive day
period, the Company shall pay to the Executive only the amount that is the difference between (i) the Executive’s Base Salary and (ii) the disability benefits paid to the Executive by the short-term and long term insurance providers.
Any dispute as to whether or not the Executive is Totally Disabled within the meaning of this Section 9(h) shall be resolved by a physician or other health care professional selected in good faith by the Executive, and approved by the Board,
which approval shall not be unreasonably withheld, and the determination of such physician or other health care professional shall be final and binding upon both the Executive and the Company. 

10.    Parachute Payments; Section 280G. 

(a)    Notwithstanding any other provisions of this Agreement to the contrary, in the event that it shall be determined
that any payment or distribution in the nature of compensation (within the meaning of Section 280G(b)(2) of the Code) to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this
Agreement or otherwise (the “Payments”), would constitute an “excess parachute payment” within the meaning of Section 280G of the Code (whether in connection with the transactions contemplated by the Merger Agreement
or any other transaction involving the Company), the Company shall reduce 

  
 11 

 
(but not below zero) the aggregate present value of the Payments to the Reduced Amount (as defined below), if reducing the Payments under this Agreement will provide the Executive with a greater
net after-tax amount than would be the case if no such reduction was made. The Payments shall be reduced as described in the preceding sentence only if (A) the net amount of the Payments, as so
reduced (and after subtracting the net amount of federal, state and local income and payroll taxes on the reduced Payments), is greater than or equal to (B) the net amount of the Payments without such reduction (but after subtracting the net
amount of federal, state and local income and payroll taxes on the Payments and the amount of Excise Tax (as defined below) to which the Executive would be subject with respect to the unreduced Payments). Any reduction shall be made in accordance
with Section 409A of the Code. For purposes of this Section 10(a), (i) the “Reduced Amount” shall be an amount expressed in present value that maximizes the aggregate present value of Payments under this Agreement
without causing any Payment under this Agreement to be subject to the Excise Tax, determined in accordance with Section 280G(d)(4) of the Code, and (ii) the term “Excise Tax” means the excise tax imposed under
Section 4999 of the Code, together with any interest or penalties imposed with respect to such excise tax. 

(b)    All determinations to be made under this Section 10 shall be made by an independent registered public
accounting firm or consulting firm selected by the Company immediately prior to a change of control, which shall provide its determinations and any supporting calculations both to the Company and the Executive within ten days of the change of
control. Any such determination by such firm shall be binding upon the Company and the Executive. All fees and expenses of the accounting or consulting firm in performing the determinations referred to in this Section 10 shall be
borne solely by the Company. The Executive may review the calculations provided by the accounting or consulting firm and may retain another accounting or consulting firm at his own expense for such review and submit objections during such ten-day review period. 
 (c)    Notwithstanding the foregoing, prior to the Effective
Date, the Company may request that Taylor Parent, LLC submit any payments or benefits under this Agreement to a vote of stockholders of Taylor Parent, LLC or an applicable affiliate if the Company determines doing so is necessary in order to avoid
such payments or benefits to the Executive being treated as a “parachute payment” under Section 280G of the Code. If the Executive’s right to any such payments or benefits are submitted to such stockholders, and such stockholders
do not approve such right in the manner prescribed by Section 280G of the Code, then the Executive’s right to such payments or benefits will be reduced or eliminated to the extent necessary to avoid any portion of such payments or benefits
being treated as a parachute payment. 
 11.    Restrictive Covenants. 

(a)    Non-Competition. During the Term, the Executive will devote his full
available business time and efforts to promoting and advancing the business of the Company. The Executive hereby agrees that during the Term and for a period of one year thereafter, he will not engage in, be employed by or participate in any way in
any country in any business that (i) the Company or any of its subsidiaries is engaging in, or is actively planning to engage in, on the effective date of the Executive’s termination of employment (including without limitation, the design,
sale, manufacture, distribution or marketing of any kitchenware, barware, bar 

  
 12 

 
accessories, coffee accessories, bakeware, pantry ware, cutlery, kitchen gadgets, flatware, home decor, garden accessories, kitchen measurement devices (including kitchen scales, kitchen
thermometers, timers and other food preparation devices), weather and outdoor products (including thermometers (both digital and analog), rain gauges, anemometers, barometers and hygrometers), bath scales, sports bottles, luggage accessories,
picture frames or related products or the licensing of trademarks and brand names therefor) or (ii) accepts or holds a license, dealership, distributorship, franchise or similar arrangement as to any trademark or product as to which the Company
is a licensee, licensor, dealer, distributor, franchisee or franchisor on the effective date of the Executive’s termination (the businesses set forth in the preceding clauses (i) and (ii) collectively, a “Competing Business”),
which engagement, employment or participation includes, but is not limited to, acting as a director, officer, employee, agent, member, manager, managing member, independent contractor, partner, general partner, limited partner, consultant,
representative, salesman, licensor or licensee, franchisor or franchisee, proprietor, syndicate member, stockholder or creditor. Notwithstanding the foregoing, the Executive may own or hold equity securities (or securities convertible into, or
exchangeable or exercisable for, equity securities) of any company or entity that engages in a business that is the same or similar to that of the Company or of its parent entities (if any) or any of its subsidiaries or affiliates; provided,
however, that (i) such equity securities are publicly traded on a securities exchange and (ii) the Executive’s aggregate holdings of such securities do not exceed at any time one (1%) percent of the total issued and outstanding equity
securities of such company or entity. 
 (b)    Non-Solicitation. The
Executive agrees that during the Term and for a period of two years thereafter: 
 (i)    Customers
and Business. The Executive will not directly or indirectly, either for himself or for any other person, business, partnership, association, firm, corporation or company (A) call upon, solicit, divert or take away or attempt to solicit,
divert or take away (1) any of the customers or prospective customers (i.e., those customers in existence or being solicited by the Company or any of its subsidiaries at the time of the Executive’s termination of employment with the
Company or within 12 months prior thereto) in connection with a Competing Business or (2) any business of the Company or any of its subsidiaries (i.e., those business arrangements concluded or being negotiated and/or developed by the Company or
any of its subsidiaries at the time of the termination of the Executive’s employment), or (B) otherwise induce or influence any such customer or prospective customer to reduce its volume of business, or terminate or divert its relationship
or otherwise in any way adversely affect its relationship, with the Company or any of its subsidiaries. 

(ii)    Employees. The Executive, on behalf of himself, or any business, firm, corporation,
partnership, association, company or any other entity other than the Company, will not solicit for employment, employ, engage, retain, discuss employment, recruit, attempt to recruit, hire or attempt to hire, or assist any other person to do so in
any manner, any person who, within the prior 12 months, was a director, officer, executive, consultant, advisor, representative or agent of the Company or any of its subsidiaries, or encourage any such person to terminate his or her employment or
other relationship with the Company or any of its subsidiaries; provided, however, that the foregoing shall not prohibit general employment solicitations not specifically targeted at directors, officers, executives, consultants, advisors,
representatives or agents of the Company or any of its subsidiaries. 

  
 13 

 (c)    Nondisclosure Obligation. The Executive acknowledges and agrees
that the Company and its subsidiaries own, control and have exclusive access to a body of existing technical knowledge and technology, and that the Company and its subsidiaries have expended and are expending substantial resources in a continuing
program of research, development and production with respect to their businesses. The Company and its subsidiaries possess and will continue to possess information that has been or will be created, discovered or developed, or has or will otherwise
become known to the Company and its subsidiaries, and/or in which property rights have been or will be assigned or otherwise conveyed to the Company and its subsidiaries, which information has commercial value in the businesses in which the Company
and its subsidiaries are engaged including information about costs, profits, markets, sales, products, key personnel, pricing policies, operational methods, technical processes and other business affairs and methods, plans for future development and
other information not readily available to the public. All of the aforementioned information is hereinafter called “Confidential Information.” The Executive acknowledges that his employment by the Company creates a relationship of
confidence and trust between the Executive and the Company and its subsidiaries, and that by reason of such employment the Executive will come into possession of, contribute to, and have access to and knowledge of Confidential Information. The
Executive further acknowledges that the services to be performed under this Agreement are of a special, unique, unusual, extraordinary and intellectual character. The Executive further acknowledges that the businesses of the Company are
international in scope, and that the nature of the Executive’s services, position and expertise are such that he is capable of competing with the Company from nearly any location in the Western hemisphere or Europe. In recognition of the
foregoing, the Executive covenants and agrees that during the Term and for five years thereafter, the Executive will use and hold such Confidential Information solely for the benefit of the Company and its subsidiaries and shall not use such
Confidential Information for the Executive’s own benefit or for the benefit of any third party. The Executive shall not, directly or indirectly, disclose or reveal such Confidential Information, in any manner, to any person other than the
Company’s executives unless such information is made or becomes public through disclosure of a party other than the Executive, or such disclosure is required by law and, then, to the extent practicable, only following prior written notice to
the Company. At the termination of his employment, the Executive shall deliver to the Company all notes, letters, documents and records which may contain Confidential Information which are then in his possession or control and shall destroy any and
all copies and summaries thereof. 
 (d)    Permitted Conduct. Nothing in this Agreement shall prohibit or
restrict the Executive from lawfully (i) initiating communications directly with, cooperating with, providing information to, causing information to be provided to, or otherwise assisting in an investigation by any governmental or regulatory
agency, entity, or official(s) (collectively, “Governmental Authorities”) regarding a possible violation of any law; (ii) responding to any inquiry or legal process directed to the Executive individually (and not directed to
the Company and/or its subsidiaries) from any such Governmental Authorities; (iii) testifying, participating or otherwise assisting in an action or proceeding by any such Governmental Authorities relating to a possible violation of law; or
(iv) making any other disclosures that are protected under the whistleblower provisions of any applicable law. Additionally, pursuant to the federal Defend Trade Secrets Act 

  
 14 

 
of 2016, the Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (A) is made (1) in
confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made to the
Executive’s attorney in relation to a lawsuit for retaliation against the Executive for reporting a suspected violation of law; or (C) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made
under seal. Nor does this Agreement require the Executive to obtain prior authorization from the Company before engaging in any conduct described in this paragraph, or to notify the Company that the Executive has engaged in any such conduct. 

(e)    Non-Disparagement. The Company and the Executive covenant and agree
that during the Term and following termination of the Term, neither party shall make any disparaging, false or abusive remarks or communications, written or oral, regarding the Executive, on the part of the Company, or the Company, the
Company’s products, brands, trademarks, directors, officers, employees, consultants, advisors, licensors, licensees, customers, vendors or others with which it has a business relationship, on the part of the Executive. 

(f)    Remedies. It is specifically understood and agreed that any breach of the provisions of this Section 11
is likely to result in irreparable injury to the Company or the Executive, as the case may be, and that the remedy at law alone will be an inadequate remedy for such breach, and that, in addition to any other remedy it may have, each party shall be
entitled to seek the specific performance of this Agreement by the other party and to seek both temporary and permanent injunctive relief (to the extent permitted by law). 

12.    Arbitration. Any controversy or claim arising out of or relating to this Agreement (or the breach thereof)
shall be settled by final and binding arbitration in New York, New York by three arbitrators. Except as otherwise expressly provided in this Section 12, the arbitration shall be conducted in accordance with the commercial rules of the American
Arbitration Association (the “Association”) then in effect. One of the arbitrators shall be appointed by the Company, one shall be appointed by the Executive, and the third shall be appointed by the first two arbitrators. If the
first two arbitrators cannot agree on the third arbitrator within 30 days of the appointment of the second arbitrator, then the third arbitrator shall be appointed by the Association. This Section 12 shall not be construed to limit the
Company’s or the Executive’s right to obtain equitable relief under this Agreement with respect to any matter or controversy subject to this Agreement, and, pending a final determination by the arbitrators with respect to any such matter
or controversy, the Company and the Executive shall be entitled to obtain any such relief by direct application to a state, federal or other applicable court, without first being required to arbitrate such matter or controversy and without the
necessity of posting a bond. 
 13.    Directors and Officers Insurance. The Executive shall be covered under the
Company’s existing directors and officers insurance policies, as in effect from time to time. 

14.    Survival. The respective rights and obligations of the parties under this Agreement (including, but not
limited to, Section 11) shall survive any termination of the Executive’s employment or termination or expiration of this Agreement to the extent necessary to the intended preservation of such rights and obligations. 

  
 15 

 15.    Section 409A. 

(a)    This Agreement is intended to comply with Section 409A of the Code or an exemption, and payments may only be
made under this Agreement upon an event and in a manner permitted by Section 409A of the Code, to the extent applicable. Severance benefits under the Agreement are intended to be exempt from Section 409A of the Code under the
“short-term deferral” exception, to the maximum extent applicable, and then under the “separation pay” exception, to the maximum extent applicable. Notwithstanding anything in this Agreement to the contrary, if required by
Section 409A of the Code, if the Executive is considered a “specified employee” for purposes of Section 409A of the Code and if payment of any amounts under this Agreement is required to be delayed for a period of six months
after separation from service pursuant to Section 409A of the Code, payment of such amounts shall be delayed as required by Section 409A of the Code, and the accumulated amounts shall be paid in a lump sum payment within ten days after the
end of the six-month period. If the Executive dies during the postponement period prior to the payment of benefits, the amounts withheld on account of Section 409A of the Code shall be paid to the
personal representative of the Executive’s estate within 60 days after the date of the Executive’s death. 

(b)    All payments to be made upon a termination of employment under this Agreement may only be made upon a
“separation from service” under Section 409A of the Code. For purposes of Section 409A of the Code, each payment hereunder shall be treated as a separate payment and the right to a series of installment payments under this
Agreement shall be treated as a right to a series of separate payments. In no event may the Executive, directly or indirectly, designate the calendar year of a payment. Notwithstanding any provision of this Agreement to the contrary, in no event
shall the timing of the Executive’s execution of the Release, directly or indirectly, result in the Executive designating the calendar year of payment of any amounts of deferred compensation subject to Section 409A of the Code, and if a
payment that is subject to execution of the Release could be made in more than one taxable year, payment shall be made in the later taxable year. 

(c)    All reimbursements and in-kind benefits provided under the Agreement shall
be made or provided in accordance with the requirements of Section 409A of the Code, including, where applicable, the requirement that (i) any reimbursement is for expenses incurred during the period of time specified in this Agreement,
(ii) the amount of expenses eligible for reimbursement, or in kind benefits provided, during a calendar year may not affect the expenses eligible for reimbursement, or in kind benefits to be provided, in any other calendar year, (iii) the
reimbursement of an eligible expense will be made no later than the last day of the calendar year following the year in which the expense is incurred, and (iv) the right to reimbursement or in kind benefits is not subject to liquidation or
exchange for another benefit. 
 16.    Notices. All notices and other communications required or permitted under
this Agreement or necessary or convenient in connection herewith shall be in writing and shall be deemed to have been given when hand delivered or mailed by registered or certified mail, as follows (provided that notice of change of address shall be
deemed given only when received): 
 If to the Company, to: 

Lifetime Brands, Inc. 
 1000
Stewart Avenue 
 Garden City, New York 11530 

Attention: Board of Directors 

  
 16 

 with a copy to: 

Lifetime Brands, Inc. 
 1000
Stewart Avenue 
 Garden City, New York 11530 

Attention: Legal Department 
 If
to the Executive, to: 
 Mr. Robert B. Kay 

or, to the most recent address on file with the Company or to such other names or addresses as the Company or the Executive, as the case may be, shall
designate by notice to each other person entitled to receive notices in the manner specified in this Section 16. 

17.    Withholding. All payments under this Agreement shall be made subject to applicable tax withholding, and the
Company shall withhold from any payments under this Agreement all federal, state and local taxes as the Company is required to withhold pursuant to any law or governmental rule or regulation. The Executive shall bear all expenses of, and be solely
responsible for, all federal, state and local taxes due with respect to any payment received under this Agreement. 

18.    Remedies Cumulative; No Waiver. No remedy conferred upon a party by this Agreement is intended to be
exclusive of any other remedy, and each and every such remedy shall be cumulative and shall be in addition to any other remedy given under this Agreement or now or hereafter existing at law or in equity. No delay or omission by a party in exercising
any right, remedy or power under this Agreement or existing at law or in equity shall be construed as a waiver thereof, and any such right, remedy or power may be exercised by such party from time to time and as often as may be deemed expedient or
necessary by such party in its sole discretion. 
 19.    Assignment. All of the terms and provisions of this
Agreement shall be binding upon and inure to the benefit of and be enforceable by the respective heirs, executors, administrators, legal representatives, successors and assigns of the parties hereto, except that the duties and responsibilities of
the Executive under this Agreement are of a personal nature and shall not be assignable or delegable in whole or in part by the Executive. The Company may assign its rights, together with its obligations hereunder, in connection with any sale,
transfer or other disposition of all or substantially all of its business and assets, and such rights and obligations shall inure to, and be binding upon, any successor to the business or any successor to substantially all of the assets of the
Company, whether by merger, purchase of stock or assets or otherwise, which successor shall expressly assume such obligations. 

  
 17 

 20.    Company Policies. This Agreement and the compensation payable
hereunder shall be subject to any applicable clawback or recoupment policies, share trading policies, and other policies that may be implemented by the Board from time to time with respect to officers of the Company. 

21.    Entire Agreement; Modifications. This Agreement sets forth the entire agreement of the parties hereto and
supersedes any and all prior agreements and understandings concerning the Executive’s employment by the Company, Taylor Holdco, LLC, or their respective affiliates and predecessors. This Agreement may be amended or modified only by a written
document signed by the Executive and the Company. 
 22.    Severability. If any provision of this Agreement or
application thereof to anyone or under any circumstances is adjudicated to be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect any other provision or application of this Agreement which can be given
effect without the invalid or unenforceable provision or application and shall not invalidate or render unenforceable such provision or application in any other jurisdiction. If any provision is held void, invalid or unenforceable with respect to
particular circumstances, it shall nevertheless remain in full force and effect in all other circumstances. 

23.    Governing Law. This Agreement shall be governed by, and construed and enforced in accordance with, the
substantive and procedural laws of the state of New York without regard to rules governing conflicts of law. Subject to Section 12, any legal action or proceeding brought with respect to this Agreement shall be brought in the state or federal
courts located in New York, New York. If the Executive prevails in any legal or arbitration proceeding commenced in connection with this Agreement, then the Company shall reimburse the Executive for reasonable attorneys’ fees and costs incurred
in connection therewith. 
 24.    Indemnification Agreement. Upon the Effective Date, the Company and the
Executive will enter into the Company’s standard indemnification agreement provided to all named executive officers of the Company. 

25.    Counterparts. This Agreement may be executed in any number of counterparts (including facsimile
counterparts), each of which shall be an original, but all of which together shall constitute one instrument. 

26.    Termination of the Merger Agreement. For the avoidance of doubt, in the event that the Merger Agreement is
terminated for any reason or the closing of the transactions contemplated by the Merger Agreement does not otherwise occur, this Agreement shall be void and shall have no force or effect. 

27.    Reimbursement of Expenses. The Company shall promptly reimburse the Executive on a one-time basis for all reasonable legal fees incurred by the Executive solely in connection with the preparation, negotiation and execution of this Agreement and any ancillary documents; provided that, such
reimbursement shall not exceed $10,000. 

  
 18 

 [Signature Page Follows] 

  
 19 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date and year first
above written. 
  

					
	LIFETIME BRANDS, INC.
		
	By:	 	      /s/ Jeffrey Siegel

		 	Name:	 	Jeffrey Siegel
		 	Title:	 	Chief Executive Officer

  

	
	EXECUTIVE
	
	             /s/ Robert B. Kay

	Robert B. Kay

  
 20 

 EXHIBIT A 

GENERAL RELEASE 
 I, Robert B. Kay,
the undersigned, agree to accept the payments and benefits set forth on Section 6 of the employment agreement between me and Lifetime Brands, Inc. (the “Company”) dated as of         
    , 2017 (the “Employment Agreement”) in full resolution and satisfaction of, and hereby IRREVOCABLY AND UNCONDITIONALLY RELEASE, REMISE AND FOREVER DISCHARGE the Company and Releasees from any and all
agreements, promises, liabilities, claims, demands, rights and entitlements of any kind whatsoever, in law or equity, whether known or unknown, asserted or unasserted, fixed or contingent, apparent or concealed, to the maximum extent permitted by
law (“Claims”), which I, my heirs, executors, administrators, successors or assigns ever had, now have or hereafter can, shall or may have for, upon, or by reason of any matter, cause or thing whatsoever existing, arising, occurring
or relating to my employment and/or termination thereof with the Company and Releasees, or my economic rights as an equity holder of the Company or Releasees, at any time on or prior to the date I execute this general release and waiver of Claims
(this “Release”), including, without limitation, any and all Claims arising out of or relating to compensation, benefits, any and all contract claims, tort claims, fraud claims, claims for bonuses, commissions, sales credits, etc.,
defamation, disparagement, or other personal injury claims, claims for accrued vacation pay, claims under any federal, state or municipal wage payment, harassment, retaliation, discrimination or fair employment practices law, statute or regulation,
and claims for costs, expenses and attorneys’ fees with respect thereto. This Release includes, without limitation, any and all rights and claims under Title VII of the Civil Rights Act of 1964, the Civil Rights Acts of 1866, 1871 and 1991,
Section 1981 of U.S.C., the Employee Retirement Income Security Act, the Age Discrimination in Employment Act (including but not limited to the Older Workers Benefit Protection Act), the Americans with Disabilities Act, the Genetic Information Non-discrimination Act, the Family and Medical Leave Act, the Equal Pay Act, New York State Human Rights Law, New York Equal Pay Law, New York Equal Rights Law, New York
Off-duty Conduct Lawful Activities Discrimination Law, New York State Labor Relations Act, Article 23-A of the New York State Corrections Law, New York Whistleblower
Statute, New York Family Leave Law, New York Minimum Wage Act, New York Wage and Hour Law, New York Wage Hour and Wage Payment Law, New York WARN Act, and retaliation provisions of New York Workers’ Compensation Law, and all amendments to the
foregoing, and any other federal, state or local statute, ordinance, regulation or constitutional provision regarding employment, compensation, employee benefits, termination of employment or discrimination in employment. 

Except as permitted by Section 11(d) of the Employment Agreement and explained below, I represent and affirm (i) that I have not filed any Claim
against the Company or Releasees and (ii) that to the best of my knowledge and belief, there are no outstanding Claims. 
 For the purpose of
implementing a full and complete release and discharge of Claims, I expressly acknowledge that this Release is intended to include in its effect, without limitation, 

  
 A-1 

 
all the Claims described in the preceding paragraphs, whether known or unknown, apparent or concealed, and that this Release contemplates the extinction of all such Claims, including Claims for
attorney’s fees. I expressly waive any right to assert after the execution of this Release that any such Claim has, through ignorance or oversight, been omitted from the scope of the Release. 

For purposes of this Release, the term “the Company and Releasees” includes the Company and its past, present and future direct and indirect
parents, subsidiaries, affiliates, divisions, predecessors, successors, and assigns, and their past, present and future officers, directors, shareholders, representatives, agents, attorneys and employees, in their official and individual capacities,
and all other related individuals and entities, jointly and individually, and this Release shall inure to the benefit of and shall be binding and enforceable by all such entities and individuals. 

Notwithstanding anything in this Release to the contrary, I do not waive (i) my existing right to receive vested accrued benefits under plans or programs
of the Company under which I have accrued benefits (other than under any Company separation or severance plan or programs), (ii) any claims that, by law, may not be waived, (iii) any right to indemnification under the governing documents of the
Company or any indemnification agreement between me and the Company, or under any directors and officers insurance policy, with respect to my performance of duties as an officer or director of the Company, (iv) any claim or right I may have for
unemployment insurance benefits, workers’ compensation benefits, state disability and/or paid family leave insurance benefits pursuant to the terms of applicable state law, and (v) my right to severance benefits pursuant to Section 6
of the Employment Agreement. 
 I understand that nothing in this Release or the Employment Agreement restricts or prohibits me from initiating
communications directly with, responding to any inquiries from, providing testimony before, providing confidential information to, reporting possible violations of law or regulation to, or from filing a claim or assisting with an investigation
directly with a self-regulatory authority or a government agency or entity, including the U.S. Equal Employment Opportunity Commission, the Department of Labor, the National Labor Relations Board, the Department of Justice, the Securities and
Exchange Commission, the Congress, and any agency Inspector General (collectively, the “Regulators”), or from making other disclosures that are protected under the whistleblower provisions of state or federal law or
regulation. However, I acknowledge that to the maximum extent permitted by law, I am waiving my right to receive any individual monetary relief from the Company or any others covered by this Release resulting from such claims or conduct, regardless
of whether I or another party has filed them, and in the event I obtain such monetary relief the Company will be entitled to an offset for the payments made pursuant to this Release and the Employment Agreement. I understand that this Release and
the Employment Agreement do not limit my right to receive an award from any Regulator that provides awards for providing information relating to a potential violation of law. I further understand that I do not need the prior authorization of the
Company to engage in conduct protected by this Paragraph, and that I do not need to notify the Company that I have engaged in such conduct. 

  
 A-2 

 I have taken notice that federal law provides criminal and civil immunity to federal and state claims for
trade secret misappropriation to individuals who disclose a trade secret to their attorney, a court, or a government official in certain, confidential circumstances that are set forth at 18 U.S.C. §§ 1833(b)(1) and 1833(b)(2), related to
the reporting or investigation of a suspected violation of the law, or in connection with a lawsuit for retaliation for reporting a suspected violation of the law. 

I acknowledge that for purposes of my entitlement to the payments and benefits set forth in Section 6 of the Employment Agreement, this Release will not
become effective unless and until I have signed and returned this Release to the Company, and have not revoked it pursuant to the following paragraph. 
 I
further acknowledge that I have had at least 21 days from my receipt of this Release, to review and consider this Release, to consult with an attorney prior to executing this Release, and have been provided 7 days to revoke my execution of this
Release by delivering a written notice of revocation to the Company. 
 I ACKNOWLEDGE THAT I HAVE READ 

THIS RELEASE, AND I UNDERSTAND 
 AND VOLUNTARILY ACCEPT ITS TERMS.

  

							
	  
	  		 	  
	  	
	Robert B. Kay	  		 	                Date	  	

  
 A-3EX-10.3

 Exhibit 10.3 

EXECUTION FORM 

STOCKHOLDERS AGREEMENT 

This Stockholders Agreement (this “Agreement”) is made and entered into as of [●], 2018, by and among Lifetime Brands,
Inc., a Delaware corporation (the “Company”) and Taylor Parent, LLC, a Delaware limited liability company (the “Taylor Parent” and, together with any other stockholder of the Company set forth on Schedule I
hereto, as may be amended from time to time after the date hereof, each a “Stockholder” and collectively, the “Stockholders”). 

WHEREAS, the Company, Taylor Parent, Taylor Holdco, LLC, a Delaware limited liability company, and CP Taylor GP, LLC, a Delaware
limited liability company, have previously entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 22, 2017, pursuant to which, following the consummation of the transactions contemplated
thereby, Taylor Holdco, LLC will become a wholly-owned subsidiary of the Company and Taylor Parent will become a stockholder of the Company; 

WHEREAS, the Company and Taylor Parent desire to enter into this Agreement to provide for (a) registration rights with respect to
the shares of Common Stock held by the Stockholder and (b) certain other governance matters and restrictions on Transfer and other matters set forth herein. 

NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows: 

Section 1. Definitions. As used in this Agreement, the following terms shall have the meanings set forth in
Section 1. Capitalized terms used, but not otherwise defined herein, shall have the meanings ascribed to such terms in the Merger Agreement. 

“Accountants” means the firm of independent certified public accountants selected by the Board. 

“Affiliate” means, with respect to any Person, any other Person which directly or indirectly, through one or more
intermediaries, controls, or is under common control with, or is controlled by, such Person. As used in this definition, “control” (including, with its correlative meanings, “controlling,” “controlled by” and
“under common control with”) shall mean possession, directly or indirectly, of power to direct or cause the direction of the actions, management or policies of the specified person (whether through ownership of securities or partnership or
other ownership interests, by contract or otherwise). 
 “Agreement” has the meaning set forth in the preamble hereto. 

“Beneficially Own” has the meaning set forth in Rule 13d-3 under the Exchange Act.

 “Board” means the Board of Directors of the Company. 

“Board Policies and Procedures” has the meaning set forth in Section 5(h). 

“Business Day” means a day other than a Saturday, Sunday or other day on which commercial banks in New York, New York are
authorized or required by Law to close. 
 “Centre Partner Funds” means the investment funds managed by Centre Partners
Management, LLC. 

  
 1 

 “Change of Control” means any of the following: (A) a sale, lease, exchange
or other transfer (in one transaction or a related series of transactions) of all or substantially all of the assets of the Company and its Subsidiaries to any single person or “group” (as defined in the Securities Exchange Act of 1934) of
persons; (B) consummation of a merger or consolidation of the Company with or into any other corporation or other entity in any event where 50% of the equity ownership or voting power of the then-outstanding capital stock of the Company is held
by any single person or “group” (as defined in the Securities Exchange Act of 1934) of persons; or (C) the sale of more than 50% of the equity ownership or voting power of the then-outstanding capital stock of the Company to any
single person or “group” (as defined in the Securities Exchange Act of 1934) of persons. 
 “Commission” means
the Securities and Exchange Commission or any other Governmental Authority at the time administering the Securities Act. 
 “Common
Stock” means (a) the Company’s common stock, par value $0.001 per share and (b) any Securities issued or issuable directly or indirectly with respect to shares of Common Stock by way of conversion, exercise or exchange, stock
dividend or stock split or in connection with a combination of shares, recapitalization, reclassification, merger, consolidation, reorganization or other similar event. 

“Company” has the meaning set forth in the preamble hereto. 

“Company Bylaws” has the meaning set forth in Section 4(a). 

“Company Certificate of Incorporation” has the meaning set forth in Section 4(a). 

“DGCL” means the General Corporation Law of the State of Delaware, as the same shall be in effect from time to time. 

“Demand Party” has the meaning set forth in Section 2(a). 

“Demand Notice” has the meaning set forth in Section 2(a). 

“Demand Registration” has the meaning set forth in Section 2(a). 

“Disinterested Directors” means all of the members of the Board other than the Taylor Parent Directors. 

“Exchange Act” means the Securities Exchange Act of 1934, and the Rules and Regulations, all as the same shall be in effect
from time to time. 
 “Fully Diluted Basis” means, as of the time of determination, the sum of (a) the number of
registered and unregistered shares of Common Stock issued and outstanding (excluding any unvested restricted shares of Common Stock), plus (b) the number of shares of Common Stock issuable upon the exercise of all vested and unvested in-the-money stock options of the Company (calculated using the treasury stock method, based on the average of the closing stock price of shares of Common Stock of the last 20
trading days prior to the date of determination, weighted for volume), plus (c) the number of shares of unvested restricted Common Stock that will vest within 12 months of the applicable date of determination pursuant to the terms of the
agreements in which such shares were granted. For purposes of the foregoing clause (c), the number of such shares that will vest by the applicable date of determination shall be calculated on the assumption that any holder of such shares as of such
date will continue to be employed by the Company or any of its Affiliates or serve as a Director of the Company or any of its Affiliates, as applicable, on the applicable date of determination. Further, for purposes of the foregoing clause (c),
shares that vest based on the performance of the Company will be derived from the Company’s audited financial statements for the applicable period, or, if such determination is required to be made prior to the finalization of the Company’s
audited financial statements, shares that vest based on performance of the Company will be derived from the Company’s annual budget, as approved by the Board for 

  
 2 

 
the final year of the applicable performance stock plan. If after the Closing the Company issues any securities to employees of the Company or any Director pursuant to a plan that is not
substantially similar to plans in effect as of the date hereof, the calculation of the Company’s outstanding shares of Common Stock on a Fully Diluted Basis shall be revised to reflect such issuance as determined by the Board in its reasonable
discretion. An illustrative example calculation of the Company’s outstanding shares of Common Stock on a Fully Diluted Basis as determined based on the assumptions set forth above is set forth as Exhibit A hereto. 

“Governmental Authority” means any Federal, state, municipal, local or foreign government, governmental authority, regulatory
or administrative agency, governmental commission, department, board, bureau, agency or instrumentality, court, tribunal, arbitrator or arbitral body. 

“Information” has the meaning set forth in Section 2(i)(xi). 

“Inspectors” has the meaning set forth in Section 2(i)(xi). 

“Issuer Free Writing Prospectus” means each “free writing prospectus” (as defined in Rule 405) prepared by or on
behalf of the Company or used or referred to by the Company in any offering of Registrable Securities pursuant to Section 2. 

“Law” means any federal, state, local, municipal or foreign order, judgment, decree, constitution, Law (including common
Law), ordinance, rule, regulation, statute or treaty, as well as any legally binding policy, guidance, interpretation, manual or binding communication of any Governmental Authority or stock exchange on which the Common Stock is listed. 

“Lock-up Period” means the period commencing on the Closing and ending on
January 1, 2020. 
 “Majority Stockholders” means Stockholders that Beneficially Own a majority of the shares of
Common Stock Beneficially Owned by the Stockholders. 
 “Nominating Committee” means the Nominating and Governance
Committee of the Board. 
 “Order” means any order, writ, judgment, injunction, decree, stipulation, determination, ruling,
subpoena or award or other decision issued, promulgated or entered by or with any Governmental Authority. 
 “Permitted Issuer
Information” means any “issuer information” (as defined in Rule 433 of the Rules and Regulations) used with the prior written consent of the Company in any offering of Registrable Securities pursuant to
Section 2. 
 “Permitted Transfer” has the meaning set forth in
Section 3(b). 
 “Permitted Transferee” has the meaning set forth in
Section 3(b). 
 “Person” shall be construed broadly and shall include, without limitation, an
individual, a partnership, a limited liability partnership, an investment fund, a limited liability company, a corporation (including not-for-profit), an association, a
joint stock corporation, a trust, estate, a joint venture, an unincorporated organization and any Governmental Authority or any other entity of any kind or nature. 

“Preliminary Prospectus” means any preliminary prospectus relating to an offering of Registrable Securities pursuant to
Section 2, including any prospectus supplement thereto, as filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations. 

“Prospectus” means the final prospectus relating to any offering of Registrable Securities pursuant to
Section 2, including any prospectus supplement thereto, as filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations. 

  
 3 

 “Records” has the meaning set forth in
Section 2(i)(xi). 
 “Registrable Securities” means at any time, with respect to any Stockholder,
shares of Common Stock held by such Stockholder until (i) such shares of Common Stock have been sold pursuant to an effective Registration Statement or (ii) such shares of Common Stock have been sold pursuant to Rule 144 promulgated under
the Securities Act. 
 “Registration Expenses” has the meaning set forth in Section 2(j). 

“Related Person” means, as to any Person, any Affiliates of such Person; provided that the Centre Partner Funds and
Centre Partner Management, LLC, shall be deemed to be Related Persons of Taylor Parent. 
 “Restricted Shares” has the
meaning set forth in Section 3(a). 
 “Road Show Material” has the meaning set forth in
Section 2(k). 
 “Rule 144” means Rule 144 of the Rules and Regulations or any successor rule
thereto or any complementary rule thereto. 
 “Rule 405” means Rule 405 of the Rules and Regulations or any successor rule
thereto or any complementary rule thereto. 
 “Rule 415” means Rule 415 of the Rules and Regulations or any successor rule
thereto or any complementary rule thereto. 
 “Rule 433” means Rule 433 of the Rules and Regulations or any successor rule
thereto or any complementary rule thereto. 
 “Rules and Regulations” means the rules and regulations of the Commission, as
the same shall be in effect from time to time. 
 “Securities” means “securities” as defined in
Section 2(a)(1) of the Securities Act and includes capital stock or other equity interests or any options, warrants or other securities that are directly or indirectly convertible into, or exercisable or exchangeable for, capital stock or other
equity interests. Whenever a reference herein to Securities is referring to any derivative securities, the rights of a holder shall apply to such derivative securities and all underlying Securities directly or indirectly issuable upon conversion,
exchange or exercise of such derivative securities. 
 “Securities Act” means the Securities Act of 1933, and the Rules and
Regulations, all as the same shall be in effect from time to time. 
 “Sellers’ Counsel” has the meaning set forth in
Section 2(i)(ii). 
 “Stockholder” and “Stockholders” have the meanings set forth in
the preamble hereto. 
 “Taylor Parent Designee” has the meaning set forth in Section 5(a). 

“Taylor Parent Designee Calculation Date” has the meaning set forth in Section 5(a). 

“Taylor Parent Directors” has the meaning set forth in Section 5(g). 

“Termination Event” means the earliest to occur of (i) the expiration of the
six-month period following such time as Taylor Parent (together with its Related Persons) ceases to Beneficially Own at least 5% of all 

  
 4 

 
outstanding Common Stock on a Fully Diluted Basis, (ii) the date of the occurrence of a Change of Control of the Company, or (iii) upon written notice by the Majority Stockholders
following (x) the removal of any Taylor Parent Designee from the Board, or the removal of Robert Kay as Chief Executive Officer or as a director of the Company, in each case without cause, which, with respect to Robert Kay, shall be as defined
in his employment agreement with the Company (and, (A) in each case unless approved by at least one Taylor Parent Designee and (B) in the case of removal of a single Taylor Parent Designee, unless the Company causes a replacement Taylor
Parent Designee selected by Taylor Parent to be appointed to the Board within thirty (30) days of such removal), (y) the failure of the Company to include in any proxy statement for an annual meeting of stockholders at which directors will be
elected, the nomination by the Board of the Taylor Parent Designees contemplated by Section 5 or (z) a material breach of the Company’s obligations under this Agreement which has not been cured within 20 Business Days following
written notice to the Company of such breach (this clause (ii)(z), a “Buyer Termination Event”). 

“Transfer” has the meaning set forth in Section 3(a). 

“Underwritten Offering” means a sale of Common Stock to an underwriter for reoffering to the public. 

Section 2. Registration Rights. 

(a) Right to Demand; Demand Notices. Subject to the provisions of this Section 2, at any time and from time to
time following the Lock-up Period, the Majority Stockholders (the “Demand Party”) shall have the right to make written requests during the term of this Agreement to the Company for
registration under and in accordance with the provisions of the Securities Act of all or part of its Registrable Securities on Form S-1, or any successor long form registration statement form, or, if
available, Form S-3, or any successor short form registration statement form (such registration, a “Demand Registration”). In no event shall the Company be required to effect more than two
Demand Registrations on Form S-1 or any successor long form registration statement form pursuant to this Section 2(a) during the term of this Agreement; provided, a Demand
Registration shall be deemed to be withdrawn and shall not be deemed to have been requested for purposes of this Section 2(a) to the extent the Company is not deemed, pursuant to Section 2(e), to
have effected such Demand Registration. All requests made pursuant to this Section 2 will specify the aggregate amount of Registrable Securities to be registered, and will also specify the intended method of transfer
thereof (a “Demand Notice”), including, if such transfer is pursuant to an Underwritten Offering, whether such offering shall be a “firm commitment” underwriting. The Company shall (i) as promptly as reasonably
practicable but in no event later than two Business Days after the receipt of a Demand Notice, give written notice thereof to all other Stockholders, which notice shall specify the number of Registrable Securities subject to the Demand Registration,
the registration statement form to be used, the names and notice information of the Demand Party and the intended method of disposition of such Registrable Securities and (ii) subject to Section 2(g), include in the
Registration Statement filed pursuant to such Demand Registration all of the Registrable Securities requested by such Stockholders for inclusion in such Registration Statement from whom the Company has received a written request for inclusion
therein within ten days after the receipt by such Stockholders of such written notice referred to in clause (i) above. Each such request by such Stockholders shall specify the number of Registrable Securities proposed to be registered and such
Stockholder shall send a copy of such request to the Demand Party. The failure of any Stockholder to respond within such 10-day period referred to in clause (ii) above shall be deemed to be a waiver of
such Stockholder’s rights under this paragraph (a) with respect to such Demand Registration. If a Stockholder sends the Company a written request for inclusion of part or all of such Stockholder’s Registrable Securities in a
registration, such Stockholder shall not be entitled to withdraw or revoke such request without the prior written consent of the Company unless, as a result of facts or circumstances arising after the date on which such request was made relating to
the Company or to market conditions, such Stockholder reasonably determines that participation in such registration would have a material adverse effect on such Stockholder. Subject to Section 2(b), promptly upon receipt of
any such Demand Notice, the Company will use its commercially reasonable efforts to cause to become effective, as soon as possible, but in any event within 90 days following receipt for a Demand Registration on Form
S-1 and 60 days after receipt for a Demand 

  
 5 

 
Registration on Form S-3, such registration under the Securities Act of the Registrable Securities that the Company has been so requested to register. The
Company shall not be required to effect more than one Underwritten Demand Registration or Underwritten Shelf Registration in any six-month period. 

(b) Company’s Right to Defer Registration. If the Company is requested to effect a Demand Registration or a Shelf Registration (as
defined below) and the Company determines in good faith that any registration of securities should not be made because it would materially interfere with any material financing, acquisition, corporate reorganization or merger or other transaction
involving the Company, including negotiations related thereto, require the Company to disclose any material nonpublic information which would reasonably be likely to be detrimental to the Company or would otherwise have a material adverse effect on
the Company’s business or financial condition (a “Valid Business Reason”), the Company shall have the right to defer such filing (but not the preparation of the Registration Statement) until such Valid Business Reason no longer
exists, but in no event for more than 90 days after the date of receipt of the request for such registration from such Demand Party; provided, however, that the Company may not defer its obligation in this manner more than 120 days in
total in any 12-month period. The Company shall give written notice to all Stockholders participating in the Demand Registration or Shelf Registration of its determination to postpone filing a Registration
Statement and of the fact that the Valid Business Reason for such postponement no longer exists, in each case, promptly after the occurrence thereof. If the Company shall so postpone the filing of a Registration Statement and if the Demand Party
within 30 days after receipt of the notice of postponement advises the Company in writing that such Demand Party has determined to withdraw such request for registration, then such Demand Registration shall be deemed to be withdrawn and shall not be
deemed to have been requested for purposes of Section 2(a). If the effective date of any Registration Statement filed would otherwise be at least 45 days, but fewer than 90 days, after the end of the Company’s fiscal
year, and the Securities Act requires the Company to include audited financials as of the end of such fiscal year, the Company may delay the effectiveness of such Registration Statement for such period (up to a maximum of 45 days) as is reasonably
necessary to include therein audited financial statements for such fiscal year. 
 (c) Shelf Registration. Any time after the Lock-up Period when the Company is eligible to use a short form registration statement under the Securities Act in connection with a secondary public offering of its equity securities, the Majority Stockholders may
request that the Company register under the Securities Act pursuant to Rule 415 promulgated under the Securities Act (a “Shelf Registration”) the sale of Registrable Securities owned by such Stockholders (“Shelf Registered
Securities”). The Company shall give written notice of such request to all of the Stockholders as promptly as reasonably practicable but in no event later than ten days before the anticipated filing date of the registration statement
relating to such Shelf Registration, and such notice shall describe the proposed Shelf Registration, the intended method of disposition of such Registrable Securities and any other information that at the time would be appropriate to include in such
notice, and offer such Stockholders the opportunity to register the number of Registrable Securities as each such Stockholder may request in writing to the Company, given within ten days after their receipt from the Company of the written notice of
such Shelf Registration. The “Plan of Distribution” section of such Shelf Registration shall permit all lawful means of disposition of Registrable Securities, including firm-commitment underwritten public offerings, block trades, agented
transactions, sales directly into the market, purchases or sales by brokers, hedging transactions, distributions to stockholders, partners or members of such Stockholders and sales not involving a public offering. With respect to each Shelf
Registration, the Company shall (i) as promptly as reasonably practicable after the written request of the Majority Stockholders, file a Registration Statement and (ii) use its commercially reasonable efforts to cause such Registration
Statement to be declared effective within 60 days after it receives a request therefor, and remain effective until there are no longer any Shelf Registered Securities. 

Upon written request made from time to time by holders of a majority of Shelf Registered Securities (the “Shelf Requesting
Holder”), which request shall specify the amount of such Shelf Requesting Holder’s Shelf Registered Securities to be sold (the “Requested Shelf Registered Securities”), the Company shall use its commercially reasonable
efforts to cause the sale of such Requested Shelf Registered Securities to be in the form of a firm commitment underwritten public offering (unless otherwise consented to by the Shelf Requesting 

  
 6 

 
Holder) if the anticipated aggregate offering price (calculated based upon the market price of the Registrable Securities on the date of such written request and including any Registrable
Securities subject to any applicable over-allotment option) to the public equals or exceeds $10,000,000.00 (including causing to be produced and filed any necessary Prospectuses or Prospectus supplements with respect to such offering). The Company
shall give written notice of such request to all other holders of Shelf Registered Securities no later than two Business Days after the Company receives such request from the Shelf Requesting Holder and, subject to
Section 2(g), include in such offering all Shelf Registered Securities as may be requested by such holders of Shelf Registered Securities for inclusion in such offering from whom the Company has received a written request
for inclusion therein within two Business Days after receipt of the Company’s notice. The managing underwriter or underwriters selected for such offering shall be selected by the Shelf Requesting Holder and shall be reasonably acceptable to the
Company. Notwithstanding the foregoing, in connection with any offering of Requested Shelf Registered Securities involving an underwritten public offering that occurs or is scheduled to occur within 30 days of a proposed registered underwritten
public offering of equity securities for the Company’s own account (a “Contemporaneous Company Offering”), the Company shall not be required to cause such offering of Requested Shelf Registered Securities to take the form of an
underwritten public offering but shall instead offer the Shelf Requesting Holder the ability to include its Requested Shelf Registered Securities in the Contemporaneous Company Offering. 

No Shelf Registration pursuant to this paragraph (c) shall be deemed a Demand Registration pursuant to
Section 2(a). 
 (d) Registration Statement Form. Registrations under this
Section 2 shall be on such appropriate registration form of the Commission (i) as shall be selected by the Company and as shall be reasonably acceptable to the Demand Party and (ii) as shall permit the transfer of
Registrable Securities in accordance with the intended method or methods of transfer specified in the Demand Party’s Demand Notice. If, in connection with any registration under this Section 2, the managing
underwriter, if any, shall advise the Company in writing that in its opinion the use of another permitted form is of material importance to the success of the offering, then such registration shall be on such other permitted form. 

(e) Effective Registration Statement. The Company shall be deemed to have effected a Demand Registration or Shelf Registration if
(i) the Registration Statement relating to such Demand Registration or Shelf Registration is declared effective by the Commission; provided, however, that no Demand Registration shall be deemed to have been requested for purposes
of Section 2(a) if (x) such registration, after it has become effective, is or becomes subject to any stop order, injunction or other Order of the Commission or other Governmental Authority or court by reason of an act
or omission by the Company and such interference is not cured within 30 days or (y) the conditions to closing specified in the purchase agreement or underwriting agreement entered into in connection with such registration are not satisfied or
waived because of an act or omission by the Company (other than a failure of the Company or any of its officers or employees to execute or deliver any closing certificate by reason of facts or circumstances existing due to actions of a Stockholder)
or (ii) at any time after the request for registration has been delivered to the Company and prior to the effectiveness of the Registration Statement, the preparation of such Registration Statement is discontinued or such Registration Statement
is withdrawn or abandoned at the request of the Demand Party or Shelf Requesting Holder (other than as contemplated by Section 2(j) unless such Stockholders have elected to pay and have paid to the Company in full the
Registration Expenses). 
 (f) Piggyback Registration. If the Company at any time proposes for any reason other than a request made
pursuant to Section 2(a) or Section 2(c) to register Common Stock under the Securities Act (other than on Form S-4 or Form
S-8 promulgated under the Securities Act or any successor forms thereto) it shall promptly, but in no event later than 20 days before the anticipated filing date, give written notice to each Stockholder of its
intention to register Common Stock and, upon the written request, given within 15 days after delivery of any such notice by the Company, of any Stockholder to include in such registration Registrable Securities (which request shall specify the
number of Registrable Securities proposed to be included in such registration), the 

  
 7 

 
Company shall use its commercially reasonable efforts to cause all such Registrable Securities to be included in such registration on the same terms and conditions as the Common Stock otherwise
being sold in such registration, and in any event, subject to Section 2(g), the Company shall include the Registrable Securities on the same terms and conditions as the Common Stock otherwise being sold in such
registration. 
 (g) Cutbacks. If the managing underwriter advises the Company that the inclusion of all such Registrable Securities
proposed to be included in any registration would interfere with the successful marketing (including pricing) of the Common Stock of the Company to be offered thereby, then the number of shares of Common Stock proposed to be included in such
registration shall be allocated among the Company and the selling Stockholders in the following order of priority: 
 (i) In
the case of a registration, pursuant to Section 2(a), 
  

	 	(A)	first, to the Registrable Securities to be offered by the Stockholders pro rata based on the number of shares of Registrable Securities Beneficially Owned; 

 

	 	(B)	then, to Common Stock to be offered by the Company, if any; and 

  

	 	(C)	then, to Common Stock to be offered by other stockholders who are not Stockholders, if any. 

(ii) In the case of a registration pursuant to Section 2(f), 

 

	 	(A)	first, to the Common Stock to be offered by the Company; 

  

	 	(B)	then, to the Registrable Securities to be offered by the Stockholders pro rata based on the number of shares of Registrable Securities Beneficially Owned; and 

 

	 	(C)	then, to Common Stock to be offered by other stockholders who are not Stockholders, if any. 

(h) Holdback Agreement. If the Company at any time shall register any shares of Common Stock under the Securities Act for sale in an
Underwritten Offering, no Stockholder who has been provided an opportunity to participate in such offering pursuant to paragraphs (a), (c) or (f) of this Section 2 shall sell, make any short sale of, grant any option
for the purchase of, or otherwise transfer, any Registrable Securities (other than those Registrable Securities included in such registration pursuant to this Agreement) without the prior written consent of the Company, for a period designated by
the Company in writing to the Stockholders, which period shall not begin more than 10 days prior to the effectiveness of the Registration Statement pursuant to which such public offering shall be made and shall not exceed 90 days after the effective
date of such Registration Statement. Upon request by the underwriter, the Stockholders shall, from time to time, enter into lock-up agreements on terms consistent with the preceding sentence. 

With respect to any Shelf Registration and offering of Requested Shelf Registered Securities that takes the form of an underwritten public
offering, the Company shall not (except as part of such offering) effect any Transfer of Common Stock (except pursuant to a Registration Statement on Form S-8), during the period beginning on the date the
Majority Stockholders deliver a request pursuant to Section 2(c) and ending on the date that is 90 days after the date of the final Prospectus relating to such offering, except as part of such Shelf Registration. Upon
request by the underwriter, the Company shall, from time to time, enter into lock-up agreements on terms consistent with the preceding sentence. 

(i) Preparation and Filing. If and whenever the Company is under an obligation pursuant to the provisions of this Agreement to use its
commercially reasonable efforts to effect the registration of any Registrable Securities, the Company shall, as expeditiously as practicable: 

(i) use its commercially reasonable efforts to cause a Registration Statement that registers such Registrable Securities to
become and remain effective for a period of 180 days or until all of such Registrable Securities have been transferred (if earlier); 

  
 8 

 (ii) furnish, at least ten days before filing a Registration Statement that
registers such Registrable Securities, any Preliminary Prospectus and the Prospectus relating thereto or any amendments or supplements relating to such a Registration Statement or such prospectuses, to one counsel acting on behalf of all selling
Stockholders selected by Taylor Parent (the “Sellers’ Counsel”), copies of all such documents proposed to be filed (it being understood that such ten day period need not apply to successive drafts of the same document proposed
to be filed so long as such successive drafts are supplied to such counsel in advance of the proposed filing by a period of time that is customary and reasonable under the circumstances), and shall use its commercially reasonable efforts to reflect
in each such document, when so filed with the Commission, such comments as the Stockholders whose Registrable Securities are to be covered by such Registration Statement may reasonably propose; 

(iii) prepare and file with the Commission such amendments and supplements to such Registration Statement and the Prospectus
used in connection therewith as may be necessary to keep such Registration Statement effective for at least a period of 180 days or until all of such Registrable Securities have been transferred (if earlier) and to comply with the provisions of the
Securities Act with respect to the sale or other transfer of such Registrable Securities; provided, that in the case of a Shelf Registration, the Company shall keep such Registration Statement effective until all Registrable Securities
covered by such Registration Statement shall have been sold, and shall comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such Registration Statement during such period in accordance with
the intended methods of disposition by the sellers thereof set forth in such Registration Statement; 
 (iv) promptly notify
the Sellers’ Counsel in writing (A) of the receipt by the Company of any notification with respect to any comments by the Commission with respect to such Registration Statement, any Preliminary Prospectus, the Prospectus or any Issuer Free
Writing Prospectus, or any request by the Commission for the amending or supplementing thereof or for additional information with respect thereto, (B) of the receipt by the Company of any notification with respect to the issuance or threatened
issuance by the Commission of any stop order suspending the effectiveness of such Registration Statement or any amendment or supplement thereto or the initiation of any proceedings for that purpose and (C) of the receipt by the Company of any
notification with respect to the suspension of the qualification of such Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purposes; 

(v) use its commercially reasonable efforts to register or qualify such Registrable Securities under such other securities or
blue sky laws of such jurisdictions as any selling Stockholder reasonably requests and do any and all other acts and things which may be reasonably necessary or advisable to enable the holders of such Registrable Securities to consummate the
transfer in such jurisdictions; provided, that the Company will not be required to (A) qualify generally to do business in any jurisdiction where it is not then so qualified or (B) take any action that would subject it to general service
of process in any such jurisdiction where it is not then so subject; 
 (vi) without limiting subsection (v) above, use
its commercially reasonable efforts to cause such Registrable Securities to be registered with or approved by such other Governmental Authorities as may be necessary by virtue of the business and operations of the Company to enable the holders of
such Registrable Securities to consummate the transfer of such Registrable Securities; 
 (vii) furnish to each selling
Stockholder and the underwriters, if any, such number of copies of such Registration Statement, any amendments thereto, any exhibits thereto or documents incorporated by reference therein (but only to the extent not publicly available on EDGAR or
the Company’s website), any Preliminary Prospectus, any Issuer Free Writing Prospectus and the Prospectus (each in conformity with the requirements of the Securities Act), and such other documents as such selling Stockholder or underwriters may
reasonably request in order to facilitate the public offering and sale or other transfer of such Registrable Securities; 

  
 9 

 (viii) notify in writing on a timely basis each selling Stockholder at any time
when the Prospectus is required to be delivered under the Securities Act, when the Company becomes aware of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes an untrue
statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing and, at the request of such Stockholder, prepare and
furnish to such Stockholder a number of copies reasonably requested by such Stockholder of a supplement to or an amendment of such Prospectus as may be necessary so that, as thereafter delivered to the offerees of such Registrable Securities, such
Prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing; 

(ix) use its commercially reasonable efforts to prevent the issuance of an Order suspending the effectiveness of a Registration
Statement, and if one is issued, use its commercially reasonable efforts to obtain the withdrawal of any Order suspending the effectiveness of a Registration Statement as soon as possible; 

(x) retain in accordance with the Rules and Regulations all Issuer Free Writing Prospectuses not required to be filed pursuant
to the Rules and Regulations; and if at any time after the date thereof any event shall have occurred as a result of which any Issuer Free Writing Prospectus, as then amended or supplemented, would conflict with the information in the Registration
Statement, the most recent Preliminary Prospectus or the Prospectus or would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under
which they were made, not misleading, or, if for any other reason it shall be necessary to amend or supplement any Issuer Free Writing Prospectus in order to effect compliance with the Securities Act and the Rules and Regulations, to notify promptly
in writing the selling Stockholders and underwriters and, if required by applicable law, to file such document and to prepare and furnish without charge to each selling Stockholder and underwriter as many copies as each such selling Stockholder and
underwriter may from time to time reasonably request of an amended or supplemented Issuer Free Writing Prospectus that will correct such conflict, statement or omission or effect compliance with the Securities Act and the Rules and Regulations; 

(xi) make available for inspection by any underwriter participating in any transfer pursuant to such Registration Statement and
any attorney, accountant or other agent retained by any such underwriter (collectively, the “Inspectors”), during normal business hours and at the offices where normally kept, all pertinent financial and other records, pertinent corporate
documents and properties of the Company (collectively, the “Records”), as shall be reasonably necessary to enable them to exercise their due diligence responsibility, and cause the Company’s officers, managers and employees to supply
all information (together with the Records, the “Information”) reasonably requested by any such Inspector in connection with such Registration Statement; provided, that any such Inspector shall agree to be bound by the confidentiality
provisions of this Section 2(i)(xi). Any of the Information that the Company determines in good faith to be confidential, and of which determination the Inspectors are so notified, shall not be disclosed by the Inspectors unless (i) the
disclosure of such Information is necessary to avoid or correct a misstatement or omission in the Registration Statement, (ii) the release of such Information is ordered pursuant to a subpoena or other Order from a Governmental Authority or
(iii) such Information has been made generally available to the public. Such Inspectors shall upon learning that disclosure of such Information is sought by a Governmental Authority, give prompt written notice to the Company and use their
reasonable commercial efforts to allow the Company, at the Company’s expense, to undertake appropriate action to prevent disclosure of the Information deemed confidential; 

(xii) in the case of an Underwritten Offering, use its commercially reasonable efforts to obtain from its Accountants a
“comfort” letter delivered to the underwriters in such offering in customary form and covering such matters of the type customarily covered by comfort letters; 

  
 10 

 (xiii) in the case of an Underwritten Offering, use its commercially reasonable
efforts to obtain from its counsel an opinion or opinions in customary form; 
 (xiv) provide a transfer agent and registrar
(which may be the same entity) for such Registrable Securities and a CUSIP number for such Registrable Securities, in each case no later than the effective date of such registration; 

(xv) upon the request of any underwriter, issue to any underwriter to which any selling Stockholder may sell Registrable
Securities in such offering, certificates evidencing such Registrable Securities; 
 (xvi) use its commercially reasonable
efforts to list such Registrable Securities on any national securities exchange on which any shares of Common Stock are listed; 

(xvii) in connection with an Underwritten Offering, participate, to the extent reasonably requested by the managing underwriter
for the offering and the selling Stockholders, in customary efforts to sell the Registrable Securities being offered, cause such steps to be taken as to ensure the good faith participation of senior management officers of the Company in “road
shows” as is customary and take such other actions as the underwriters or the selling Stockholders may reasonably request in order to expedite or facilitate the transfer of Registrable Securities; 

(xviii) reasonably cooperate with each Stockholder and each underwriter participating in the transfer of Registrable Securities
and their respective counsel in connection with any filings required to be made with the Financial Industry Regulatory Authority, Inc. (“FINRA”), including, if appropriate, the pre-filing of
the Prospectus as part of a Shelf Registration in advance of an Underwritten Offering; 
 (xix) during the period when the
Prospectus is required to be delivered under the Securities Act, promptly file all documents required to be filed with the Commission, including pursuant to Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act; 

(xx) otherwise use its commercially reasonable efforts to comply in all material respects with all applicable Rules and
Regulations; and 
 (xxi) use its commercially reasonable efforts to take all other steps necessary to effect the
registration of such Registrable Securities contemplated hereby. 
 (j) Expenses. All expenses incident to the Company’s
performance of, or compliance with, this Section 2, including (i) all registration and filing fees, and any other fees and expenses associated with filings required to be made with any stock exchange, the Commission
and FINRA (including, if applicable, the fees and expenses of any “qualified independent underwriter” and its counsel as may be required by the rules and regulations of FINRA); (ii) all fees and expenses of compliance with state securities
or “blue sky” Laws (including fees and disbursements of counsel for the underwriters or Stockholders in connection with “blue sky” qualifications of the Registrable Securities and determination of their eligibility for investment
under the Laws of such jurisdictions as the managing underwriters may designate); (iii) all printing and related messenger and delivery expenses (including expenses of printing certificates for the Registrable Securities in a form eligible for
deposit with The Depository Trust Company (or any other depositary or transfer agent/registrar) and of printing any Preliminary Prospectus, any Issuer Free Writing Prospectus and the Prospectus and any amendments thereto); (iv) all fees and
disbursements of counsel for the Company and of all independent certified public accountants of the issuer (including the expenses of any special audit and “comfort” letters required by or incident to such performance); (v) all Securities
Act liability insurance if the Company so desires or the underwriters so require; (vi) all fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange; and (vii) all reasonable and
documented fees and disbursements of one Sellers’ Counsel in connection with such registration (all such expenses being herein called “Registration Expenses”), will be borne by the Company, regardless of whether the
Registration Statement becomes effective; provided, however, that all underwriting discounts and selling commissions applicable to the Registrable Securities shall not be borne by the Company, but shall be borne by the seller or
sellers thereof, in proportion to 

  
 11 

 
the number of Registrable Securities sold by such seller or sellers. In addition, the Company will, in any event, pay its internal expenses (including, without limitation, all salaries and
expenses of its officers and employees performing legal or accounting duties), the expense of any audit and the fees and expenses of any Person, including special experts, retained by the Company. 

(k) Indemnification. 

(i) In connection with any registration of any Registrable Securities under the Securities Act pursuant to this Agreement, the Company shall
indemnify and hold harmless each seller (including its stockholders, partners, members, directors, managers, officers, employees, trustees and Affiliates) of such Registrable Securities, each underwriter, broker or any other Person acting on behalf
of such seller and each other Person, if any, who controls any of the foregoing Persons within the meaning of the Securities Act against any losses, claims, damages or liabilities and expenses, joint or several, to which any of the foregoing Persons
may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (1) any untrue statement or alleged untrue statement of a material
fact contained in (A) any Preliminary Prospectus, the Registration Statement, the Prospectus or in any amendment or supplement thereto, (B) any Issuer Free Writing Prospectus or in any amendment or supplement thereto, (C) any
Permitted Issuer Information used or referred to in any “free writing prospectus” (as defined in Rule 405) used or referred to by any underwriter or (D) any “road show” (as defined in Rule 433) not constituting an Issuer
Free Writing Prospectus, when considered together with the most recent Preliminary Prospectus (collectively, “Road Show Material”), (2) the omission or alleged omission to state in any Preliminary Prospectus, the Registration
Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Permitted Issuer Information or any Road Show Material any material fact required to be stated therein or necessary to make the
statements therein (in the case of any Preliminary Prospectus, Issuer Free Writing Prospectus, Permitted Issuer Information, Road Show Material and the Prospectus, in the light of the circumstances under which they were made) not misleading or
(3) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any other federal law, any state or foreign securities law, or any rule or regulation promulgated under any of the foregoing laws, relating to the
offer or sale of the Registrable Securities or blue sky Laws applicable to the Company and relating to action or inaction required of the Company in connection with such registration or qualification under such state securities or blue sky Laws; and
the Company shall reimburse such seller (including its stockholders, partners, members, directors, managers, officers, employees, trustees, attorneys, advisors and Affiliates), such underwriter, such broker or such other Person acting on behalf of
such seller and each such controlling Person for any legal or other expenses reasonably incurred by any of them in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that
the Company shall not be liable in any such case to the extent that any such loss, claim, damage or liability (or action in respect thereof) arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged
omission made in the Preliminary Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any such amendment or supplement thereto or in any Permitted Issuer Information or any Road Show Material in reliance
upon and in conformity with written information furnished to the Company through an instrument duly executed by such seller or underwriter specifically for use in the preparation thereof. 

(ii) In connection with any registration of Registrable Securities under the Securities Act pursuant to this Agreement, each seller of
Registrable Securities shall indemnify and hold harmless (in the same manner and to the same extent as set forth in the preceding paragraph of this Section 2(k)) the Company, each officer of the Company who shall sign such
Registration Statement, each underwriter, broker or other Person acting on behalf of such seller, each Person who controls any of the foregoing Persons within the meaning of the Securities Act and each other seller of Registrable Securities under
such Registration Statement with respect to any statement or omission from any Preliminary Prospectus, the Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Road Show
Material, if such statement or omission was made in reliance upon and in conformity with written information furnished to the Company or such underwriter through an instrument duly executed by such seller specifically for use in

  
 12 

 
connection with the preparation of such Preliminary Prospectus, Registration Statement, Prospectus, Issuer Free Writing Prospectus or in any amendment or supplement thereto or in any Road Show
Material; provided, however, that the obligation to indemnify shall be individual, not joint and several, for each seller and that the maximum amount of liability in respect of such indemnification shall be, limited, in the case of
each seller of Registrable Securities, to an amount equal to the net proceeds actually received by such seller from the sale of Registrable Securities effected pursuant to such registration. 

(iii) Indemnification similar to that specified in Sections 2(k)(i) and (k)(ii) shall be given by the Company and each seller
of Registrable Securities (with such modifications as may be appropriate) with respect to any required registration or other qualification of their Registrable Securities under any Federal or state Law or regulation of Governmental Authority other
than the Securities Act. 
 (iv) Promptly after receipt by an indemnified party of notice of the commencement of any action involving a
claim referred to in the preceding paragraphs of this Section 2(k), such indemnified party will, if a claim in respect thereof is made against an indemnifying party, give written notice to the latter of the commencement of
such action (provided, however, that an indemnified party’s failure to give such notice in a timely manner shall not relieve the indemnifying party of any liability that it may have to the indemnified party hereunder except to the
extent that the indemnifying party forfeits substantive rights or defenses by reason of such failure). In case any such action is brought against an indemnified party, the indemnifying party will be entitled to participate in and to assume the
defense thereof at its own expense, jointly with any other indemnifying party similarly notified to the extent that it may wish, with counsel reasonably satisfactory to such indemnified party, and after notice from the indemnifying party to such
indemnified party of its election so to assume the defense thereof, the indemnifying party shall not be responsible for any legal or other expenses subsequently incurred by the indemnified party in connection with the defense thereof. The
indemnified party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be paid by the indemnified party unless (i) the indemnifying party
agrees to pay the same, (ii) the indemnifying party fails to assume the defense of such action with counsel reasonably satisfactory to the indemnified party or (iii) the named parties to any such action (including any impleaded parties)
include both the indemnifying party and the indemnified party and such parties have been advised by such counsel that either (A) representation of such indemnified party and the indemnifying party by the same counsel would be inappropriate
under applicable standards of professional conduct or (B) there may be one or more legal defenses available to the indemnified party which are different from or additional to those available to the indemnifying party. In any of such cases, the
indemnifying party shall not have the right to assume the defense of such action on behalf of such indemnified party; it being understood, however, that the indemnifying party shall not be liable for the fees and expenses of more than one separate
firm of attorneys (in addition to any local counsel) for all indemnified parties. No indemnifying party shall be liable for any settlement entered into without its written consent, which consent shall not be unreasonably withheld. No indemnifying
party shall, without the written consent of such indemnified party, effect any settlement of any pending or threatened proceeding in respect of which such indemnified party is a party and indemnity has been sought hereunder by such indemnified
party, unless such settlement includes an unconditional release of such indemnified party from all liability for claims that are the subject matter of such proceeding. 

(v) If the indemnification provided for in this Section 2(k) is held by a court of competent jurisdiction to be
unavailable to an indemnified party with respect to any loss, claim, damage or liability referred to herein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amounts paid or payable by
such indemnified party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other in connection with the
statements or omissions which resulted in such loss, claim, damage or liability as well as any other relevant equitable considerations; provided, however, that the maximum amount of liability in respect of such contribution shall be
limited, in the case of each seller of Registrable Securities, to an amount equal to the net proceeds actually received by such seller from the sale of Registrable Securities effected pursuant to such registration. The relative fault of the
indemnifying party and of the 

  
 13 

 
indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to
information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. No Person guilty of fraud shall be
entitled to indemnification or contribution hereunder. 
 (vi) The indemnification and contribution provided for under this Agreement will
remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party and will survive the transfer of Registrable Securities and the termination of this Agreement. 

(l) Underwritten Offerings. Notwithstanding anything to the contrary set forth in this Agreement to the extent that the Company and all
the Stockholders selling Registrable Securities in a proposed registration shall enter into an underwriting or similar agreement on terms reasonably acceptable to the Company, which agreement contains provisions covering one or more issues addressed
in this Section 2, the provisions contained in this Section 2 addressing such issue or issues shall be of no force or effect with respect to such registration; provided, however, that
paragraph (k) of this Section 2 shall remain in full force and effect unless such underwriting or similar agreement states that the indemnification provisions of such agreement supersede paragraph (k) of this
Section 2. If any offering pursuant to a Demand Registration involves an Underwritten Offering, the Demand Party shall have the right to select the managing underwriter or underwriters to administer the offering, which
managing underwriters shall be a firm of nationally recognized standing and reasonably acceptable to the Company. Notwithstanding anything to the contrary set forth in this Agreement, in no event will the Company be required to effect more than one
Underwritten Offering of Registrable Securities during any six month period. 
 (m) Information by Holder. Each holder of Registrable
Securities to be included in any registration shall furnish to the Company such written information regarding such holder and the distribution proposed by such holder as the Company may reasonably request in writing and as shall be reasonably
required in connection with any registration, qualification or compliance referred to in this Agreement. 
 (n) Exchange Act
Compliance. From and after the date a Registration Statement filed by the Company pursuant to the Exchange Act relating to any class of its Securities shall have become effective, the Company shall comply with all of the reporting requirements
of the Exchange Act and shall comply with all other public information reporting requirements of the Commission which are conditions to the availability of Rule 144 for the sale of Registrable Securities. The Company shall cooperate with each holder
in supplying such information as may be necessary for such holder to complete and file any information reporting forms presently or hereafter required by the Commission as a condition to the availability of Rule 144 or any comparable successor
rules). The Company shall furnish to any holder of Registrable Securities upon request a written statement executed by the Company as to the steps it has taken to comply with the current public information requirement of Rule 144 (or such comparable
successor rules). The Company shall use its commercially reasonable efforts to facilitate and expedite transfers of Registrable Securities pursuant to Rule 144 under the Securities Act, which efforts shall include timely notice to its transfer agent
to expedite such transfers of Registrable Securities. 
 (o) Termination of Registration Rights. No Stockholder shall have any rights
under this Section 2 upon such Stockholder ceasing to Beneficially Own any Registrable Securities. 
 Section 3. Transfer Restrictions.

 (a) During the Lock-Up Period, no Stockholder shall, directly or indirectly, sell, offer or
agree to sell, or otherwise transfer, or loan or pledge (other than a pledge in connection with a bona fide third party debt financing), through swap or hedging transactions, or grant any option to purchase, make any short sale or otherwise dispose
of (“Transfer”), any of the shares of Common Stock, whether now owned or hereinafter acquired or owned directly by such Stockholder (including holding as a custodian) (collectively the “Restricted Shares”). 

  
 14 

 (b) Notwithstanding anything to the contrary set forth herein, a Stockholder may Transfer
Restricted Shares as set forth below (each, a “Permitted Transfer” and the transferee permitted hereby, a “Permitted Transferee”)): 

(i) (x) as a bona fide gift or gifts, provided that the donee or donees thereof agree to be bound in writing by the
restrictions set forth herein, (y) to any trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned, provided that the trustee of the trust agrees to be bound in writing by the restrictions set forth
herein, and provided, that any such transfer shall not involve a disposition for value, or (c) with the prior written consent of the Company. For purposes of this Agreement, “immediate family” shall mean any relationship by
blood, marriage or adoption, not more remote than first cousin; or 
 (ii) if the Stockholder is a corporation or limited
liability company, the corporation or limited liability company or other legal entity may Transfer Restricted Shares to any Related Person of such Stockholder. 

It shall be a condition to any Permitted Transfer that the Permitted Transferee execute a joinder to this Agreement in form and substance reasonably
satisfactory to the Company (at which time, such Permitted Transferee’s name will be added to Schedule I, and such Permitted Transferee will be deemed a Stockholder for purposes of this Agreement); provided, that the foregoing
restrictions shall not apply to the establishment of a trading plan pursuant to Rule 10b5-1 under the Exchange Act for the transfer of Common Stock; provided, however, that such plan does
not provide for the transfer of Common Stock during the Lock-Up Period and no public announcement or filing under the Exchange Act regarding the establishment of such plan shall be required of or voluntarily
made by or on behalf of the undersigned or the Company. Each Stockholder agrees and consents to the entry of stop transfer instructions with the Company’s transfer agent and registrar against the transfer of any Restricted Shares except in
compliance with the foregoing restrictions; provided that the Company shall cause such stop transfer instructions to be terminated upon expiration of the Lock-up Period. 

(c) Any attempt to Transfer any Restricted Shares in violation of the terms of this Agreement shall be null and void ab initio
and no right, title or interest therein or thereto shall be Transferred to the purported Transferee. The Company will not give, and will not permit the Company’s transfer agent to give, any effect to such attempted Transfer on its
records. 
 (d) Each certificate representing shares of Common Stock held by a Stockholder will bear a legend in substantially the following
form: 
 “The securities represented by this certificate have not been registered under the United States Securities Act of 1933, as
amended (the “Act”), or applicable state securities Laws and the holder of such securities may not, directly or indirectly, sell, offer or agree to sell such securities, or otherwise transfer, directly or indirectly, or loan or pledge,
through swap or hedging transactions (or other transaction which is designed to or which reasonably could be expected to lead to or result in a sale or disposition of such securities even if such securities would be disposed of by someone other than
such holder thereof) such securities (“Transfer”) other than in accordance with the terms and conditions of the Stockholders Agreement, dated as of [●], 2018, as it may be amended from time to time by and among Lifetime
Brands, Inc. (the “Company”) and certain of its stockholders and other persons (the “Stockholders Rights Agreement”). The Stockholders Agreement contains, among other things, significant restrictions on the Transfer of the
securities of the Company and other restrictions on the actions by certain stockholders of the Company relating to the Company and/or its securities. A copy of the Stockholders Agreement is available upon request from the Company.” 

(e) This Section 3 shall terminate upon a Buyer Termination Event. 

  
 15 

 Section 4. Stockholder Actions; Standstill Restrictions; Voting Agreement. 

(a) Each Stockholder agrees that, prior to the termination of this Section 4, without the prior express written
consent of a majority of the Disinterested Directors specifically expressed in a written resolution, or except as expressly contemplated by Section 5 of this Agreement, such Stockholder will not, and each Stockholder will
cause each of its respective Related Persons not to, directly or indirectly, alone or acting in concert with others, in any manner: 
 (i)
propose or publicly announce or otherwise publicly disclose an intent to propose or enter into or agree to enter into, singly or with any other person, directly or indirectly, (x) any form of business combination or acquisition or other similar
transaction relating to assets or securities of the Company or any of its subsidiaries, (y) any form of restructuring, recapitalization or similar transaction with respect to the Company or any of its subsidiaries or (z) any form of
tender or exchange offer for the Common Stock, whether or not such transaction involves a Change of Control of the Company; 
 (ii) engage
in any solicitation of proxies or written consents to vote any voting securities of the Company, or conduct any non-binding referendum with respect to any voting securities of the Company, or knowingly assist or participate in any other way,
directly or indirectly, in any solicitation of proxies or written consents with respect to any voting securities of the Company, or otherwise become a “participant” in a “solicitation,” as such terms are defined in Instruction 3
of Item 4 of Schedule 14A and Rule 14a-1 of Regulation 14A, respectively, under the Exchange Act, in each case to vote any securities of the Company in opposition to any recommendation or proposal of the
Board; 
 (iii) (A) seek to advise, knowingly encourage or knowingly influence any stockholder of the Company not a party to this Agreement
with respect to the voting of (or execution of a written consent in respect of) or (B) knowingly encourage the disposition of any securities of the Company, in each case, except with respect to any stockholder who is a Permitted Transferee;

 (iv) call or seek to call, or request the call of, alone or in concert with others, any meeting of stockholders, whether or not such a
meeting is permitted by the Company’s Amended and Restated Certificate of Incorporation (the “Company Certificate of Incorporation”) or the Company’s Amended and Restated Bylaws (the “Company Bylaws”),
including, but not limited to, a “town hall meeting”; 
 (v) seek representation on the Board, except as expressly permitted by
this Agreement; 
 (vi) initiate, knowingly encourage or participate in (other than voting such Stockholder’s Registrable Securities)
any “vote no,” “withhold” or similar campaign; 
 (vii) deposit any Common Stock in any voting trust or subject any
Common Stock to any arrangement or agreement with respect to the voting of any Common Stock; 
 (viii) seek, or encourage any person, to
submit nominations to the Board in furtherance of a “contested solicitation” for the election or removal of directors from the Board or seek or knowingly encourage the removal of any members of the Board or the election of any directors
(other than nominees recommended by the Board) or with respect to the submission of any stockholder proposals (including, but not limited to, any submission of stockholder proposals pursuant to Rule 14a-8 under the Exchange Act); 

(ix) form, join or in any other way participate in any “group” (within the meaning of Rule
13d-3 of the Exchange Act) with respect to the Common Stock for the purpose of taking any action restricted by this Section 4; 

(x) demand a copy of the Company’s list of stockholders, whether pursuant to Section 220 of the DGCL or pursuant to any other
statutory right; 

  
 16 

 (xi) acquire, offer or propose to acquire, or agree to acquire, directly or indirectly, whether
by purchase, tender or exchange offer, through the acquisition of control of another person, by joining a partnership, limited partnership, syndicate or other group (including any group of persons that would be treated as a single “person”
under Section 13(d) of the Exchange Act), through swap or hedging transactions or otherwise, any additional securities (including common and preferred equity interests and debt that is convertible into any equity interests) of the Company or
any rights decoupled from the underlying securities of the Company; 
 (xii) transfer any securities (including common and preferred equity
interests, derivative securities and debt that is convertible into any equity interests) of the Company or any rights decoupled from the underlying securities to any Person that would, to such Stockholder’s knowledge, result in such person or
entity having Beneficial Ownership representing in the aggregate in excess of 5% of the Common Stock at such time; 
 (xiii) enter into any
negotiations, agreements or understandings with any Person with respect to any of the foregoing, or make any statement inconsistent with any of the foregoing; or 

(xiv) take any action challenging the validity or enforceability of any of the provisions of this Section 4 or publicly disclose,
or cause the public disclosure (including, without limitation, the filing of any document with the Commission or any other Governmental Authority or any disclosure to any journalist, member of the media or securities analyst) of, any intent,
purpose, plan or proposal to either (A) obtain any waiver or consent under, or any amendment of, any provision of this Section 4, or (B) take any action challenging the validity or enforceability of any provisions
of this Section 4. 
 (b) The provisions set forth in Section 4(a) shall not limit the actions of any
Taylor Parent Designee or the Chief Executive Officer of the Company in his or her capacity as a director or officer of the Company, recognizing that such actions are subject to such person’s fiduciary duties to the Company and its
stockholders. 
 (c) Nothing in Section 3 or in this Section 4 shall restrict any
Stockholder or its Related Persons from tendering Shares of Common Stock into a tender offer approved by the Board. 
 (d) Each of the
Stockholders represents and warrants to the Company that, as of the date hereof, neither it, nor any of their respective Affiliates are engaged in any discussions or negotiations with any Person, and do not have any agreements, arrangements, or
understandings, written or oral, formal or informal, and whether or not legally enforceable with any Person concerning the acquisition of Beneficial Ownership of any securities of the Company. 

(e) No later than ten calendar days following the Closing, Taylor Parent shall file a Schedule 13D with the Commission with respect to the
Company reporting the entry into this Agreement, responding to applicable items of Schedule 13D to conform to their obligations thereunder and appending or incorporating by reference this Agreement as an exhibit thereto. Taylor Parent shall provide
the Company and its counsel a reasonable opportunity to review and comment on the Schedule 13D prior to such filing, which comments shall be considered in good faith. During the term of this Agreement, Taylor Parent shall provide the Company and its
counsel a reasonable opportunity to review and comment on any amendment to such Schedule 13D prior to such filing, which comments shall be considered in good faith, 

(f) This Section 4 shall terminate upon a Termination Event. 

Section 5. Taylor Parent Designees. 

(a) From and after the Closing, subject to the other provisions of this Section 5, the Company and Taylor Parent
shall cooperate to ensure that, to the greatest extent possible, the Board includes among its membership a number of Directors designated by Taylor Parent for election or appointment as Directors (the “Taylor Parent Designees”) as
follows: (A) if Taylor Parent Beneficially Owns Common Stock constituting not 

  
 17 

 
less than 20% of all outstanding Common Stock on a Fully Diluted Basis as of the Taylor Parent Designee Calculation Date, there shall be two Taylor Parent Designees; (B) if Taylor Parent
Beneficially Owns Common Stock constituting less than 20% but more than 10% of all outstanding Common Stock on a Fully Diluted Basis as of the Taylor Parent Designee Calculation Date, there shall be one Taylor Parent Designee; and (C) if Taylor
Parent Beneficially Owns Common Stock constituting less than 10% of all outstanding Common Stock on a Fully Diluted Basis as of the Taylor Parent Designee Calculation Date, there shall be no Taylor Parent Designees and Taylor Parent shall not have
the right to designate any directors to the Board. For purposes of this Agreement, the Taylor Parent Designee Calculation Date shall mean the close of business on the date that is 60 days prior to the first anniversary of the Company’s annual
meeting of stockholders for the immediately preceding year. For the avoidance of doubt, if on or at any time prior to a Taylor Parent Designee Calculation Date, Taylor Parent ceases to Beneficially Own Common Stock constituting (i) less than
20% of all outstanding Common Stock on a Fully Diluted Basis, then Taylor Parent shall at all times, for purposes of this Section 5, be deemed to Beneficially Own Common Stock constituting less than 20% of all outstanding
Common Stock on a Fully Diluted Basis and (ii) less than 10% of all outstanding Common Stock on a Fully Diluted Basis, then Taylor Parent shall at all times, for purposes of this Section 5, be deemed to Beneficially
Own Common Stock constituting less than 10% of all outstanding Common Stock on a Fully Diluted Basis; provided, that such ownership levels shall be determined without giving effect to any dilutive issuances of Common Stock or of instruments
convertible into or exchangeable or exercisable for Common Stock made after the date hereof. For all purposes of this Section 5, Taylor Parent shall be deemed to Beneficially Own all shares of Common Stock Beneficially
Owned by its Related Persons. 
 (b) If at any time the number of Taylor Parent Designees serving as Directors exceeds the number provided
for in Section 5(a), Taylor Parent shall immediately procure the resignation of such number of Taylor Parent Designees as shall be required to cause the composition of the Board to be consistent with
Section 5(a) (it being understood that it shall be in the Board’s sole discretion whether to accept or reject such resignation). As a condition to commencement of a term of a Taylor Parent Designee on the Board (or any
nomination thereof by the Company), and in furtherance of this Section 5(b), the Stockholders agree that the Taylor Parent Designees shall submit an irrevocable letter of resignation from the Board, in the form attached
hereto as Exhibit B, conditional upon acceptance by the Board (it being understood that it shall be in the Board’s sole discretion whether to accept or reject such resignation), in the event that the number of Taylor Parent Designees
serving as Directors of the Company exceeds the number provided for in Section 5(a). 
 (c) The Taylor Parent
Designees shall immediately resign (and shall be deemed hereby to have irrevocably agreed to so resign pursuant to the irrevocable letters of resignation submitted by the Taylor Parent Designees, it being understood that it shall be in the
Board’s sole discretion whether to accept or reject such resignation) and the Company’s obligations under this Section 5 shall terminate effective immediately upon such time as any Stockholder, Centre Partners (or
any Centre Partners Fund) or any of their respective Affiliates nominates, or notifies the Company in accordance with the Company’s bylaws of its intent to nominate, or present the nomination of, any directors for election to the Board,
presents any stockholder proposal, or notifies the Company in accordance with the Company’s bylaws of an intent to present any stockholder proposal, at any annual or special meeting of stockholders, or initiates a consent solicitation under the
Rules of the Exchange Act to obtain an action by written consent of the Company’s stockholders, in each case prior to the occurrence of a Termination Event or any Stockholder or any of their respective Related Persons, in each case prior to the
occurrence of a Termination Event, otherwise materially breaches Section 4 of this Agreement, which breach is not cured within 20 Business Days following written notice from the Company to the Majority Stockholders of such breach. 

  
 18 

 (d) Subject to compliance with applicable laws and the regulations of any exchange on which the
Common Stock may from time to time be traded, in connection with each annual meeting of the Company’s stockholders, the following procedures shall be followed with respect to the nomination of the Taylor Parent Designees: 

(i) the Board or the Nominating Committee of the Board (the “Nominating Committee”) shall nominate for
election to the Board at the annual meeting of stockholders Robert B. Kay or, if he is no longer the Chief Executive Officer of the Company, the most senior executive officer of the Company; and 

(ii) Taylor Parent shall designate for nomination by the Board or the Nominating Committee the number of persons Taylor Parent
is entitled to designate pursuant to Section 5(a), based on the aggregate Beneficial Ownership of Taylor Parent and its Related Persons as of the Taylor Parent Designee Calculation Dater. 

(e) Each individual designated by Taylor Parent for nomination as a director of the Company in accordance with this
Section 5 shall be nominated by the Board or the Nominating Committee for election as a Director following the Nominating Committee’s interview of each such individual and review of such individual’s
qualifications, including, but not limited to, such individual’s independence status, to serve on the Board unless the Nominating Committee reasonably determines that (i) by virtue of such individual’s character, background,
experience or qualifications the nomination of such individual would be inconsistent with the Board’s fiduciary duties to stockholders, (ii) such individual is an officer, director, partner, principal stockholder or Affiliate of any
competitor of the Company, (iii) such individual would not qualify as an independent director pursuant to NASDAQ’s listing rules relating to director independence, as then in effect, or (iv) such individual is an Affiliate of a
stockholder (other than the Stockholders) who is a party to a Schedule 13D filed with the SEC relating to the Company. If the Nominating Committee determines that any individual designated by Taylor Parent does not satisfy the criteria set forth in
the preceding sentence, the Nominating Committee will promptly notify Taylor Parent of such determination and Taylor Parent will be entitled to designate another individual for nomination. 

(f) The Company shall use its commercially reasonable efforts to solicit from the stockholders of the Company eligible to vote for the
election of Directors proxies in favor of the Taylor Parent Nominees designated in accordance with this Section 5 in substantially the same manner that it solicits proxies for all other director nominees recommended by the
Board. 
 (g) The Company shall use its commercially reasonable efforts to, effective as of the Closing, cause the Board to appoint, subject
to Section 5(e), each of Robert B. Kay, Bruce Pollack and Michael Schnabel (collectively, with any other Taylor Parent Designee elected or otherwise serving as a Director of the Company, the “Taylor Parent
Directors”), to the Board with a term on the Board expiring at the Company 2018 Annual Meeting of Stockholders and until his respective successor is duly elected and qualified. 

(h) No later than five Business Days following the execution of this Agreement, Taylor Parent shall provide the Board’s Nominating
Committee with completed and executed directors’ and officers’ questionnaires (in the form customarily used for the Company independent or non-management directors). 

(i) Taylor Parent acknowledges that the Taylor Parent Directors shall be required to comply with all policies, processes, procedures, codes,
rules, standards, and guidelines applicable, from time to time, to members of the Board, including, but not limited to, the Company’s Code of Conduct, and policies on confidentiality, ethics, hedging and pledging of the Company’s
securities, public disclosures, stock trading, and stock ownership (collectively, the “Board Policies and Procedures”), and that each of the Taylor Parent Directors shall be required to strictly preserve the confidentiality of the
Company’s business and information, including, but not limited to, the discussion of any matters considered in meetings of the Board whether or not the matters relate to material non-public information,
unless previously publicly disclosed by the Company. The Taylor Parent Directors and 

  
 19 

 
Taylor Parent shall provide the Company with such information as is reasonably requested by the Company concerning the Taylor Parent Designees and Taylor Parent Directors as is required to be
disclosed under applicable Law or stock exchange regulations, including the completion of the Company’s current standard director and officer questionnaire for all independent or non-management directors,
in each case as promptly as necessary to enable the timely filing of the Company’s proxy statement on Schedule 14A and periodic reports on Forms 10-K and 10-Q with
the Commission. 
 (j) The Company agrees that the Taylor Parent Directors shall receive the same benefits of director and officer
insurance, and any indemnity and exculpation arrangements available to the other directors on the Board. 
 (k) The Company and Taylor
Parent agree that, concurrent with the appointment of Robert B. Kay to the Board, the Board, including each of the Taylor Parent Directors, shall take such action as is necessary such that Jeffrey Siegel is appointed as executive Chairman of the
Board. Without limiting the generality of the foregoing, Taylor Parent shall, and shall cause each Taylor Parent Director to, take such action as is reasonably necessary to cause the Board to appoint Jeffrey Siegel to serve as the executive Chairman
of the Board during the term of this Agreement and be vested with all the powers and authority that an executive Chairman customarily possesses. For the avoidance of doubt, none of the Taylor Parent Directors shall serve as the Company’s Lead
Independent Director during the term of this Agreement. 
 (l) In the event any Law, rule or regulation comes into force or effect
(including by amendment), including any applicable rules of NASDAQ or the SEC, which conflicts with the terms and conditions of this Agreement, the parties shall negotiate in good faith to revise the Agreement to achieve the parties’ intention
set forth herein. 
 (m) This Section 5 shall terminate upon written notice by the Company following a material
breach of Taylor Parent’s obligations under this Agreement which has not been cured within 20 Business Days following written notice to Taylor Parent of such breach (a “Company Termination Event”). 

Section 6. Company Restricted Actions. 

During the term of this Agreement, for so long as Taylor Parent, together with its Permitted Transferees, Beneficially Owns Common Stock
constituting not less than 50% of the Equity Consideration and Taylor Parent Designees serve as Directors on the Board, neither the Company nor any of its Subsidiaries shall, without the prior written consent of the Taylor Parent Designees, which
consent shall not be unreasonably withheld, conditioned or delayed, take any of the following actions: 
 (a) enter into any agreement for a
transaction that would result in a Change of Control of the Company; 
 (b) consummate any transaction for the sale of all or substantially
all of the Company’s assets; 
 (c) file for reorganization pursuant to Chapter 11, or for liquidation pursuant to Chapter 7, of the
U.S. Bankruptcy Code; 
 (d) liquidate or dissolve the business and affairs of the Company; 

(e) take any Board actions to seek an amendment to the Company Certificate of Incorporation or approve, or recommend that the Company’s
stockholders approve, an amendment to the Company Bylaws, except as required by DE Law as defined in the Merger Agreement or other applicable law and other than amendments that would not materially and disproportionately affect Taylor Parent; 

  
 20 

 (f) incur Funded Debt in excess of $100,000,000 in the aggregate, except for the Debt Financing
or borrowings under financing arrangements of the Company or its Subsidiaries existing as of the date hereof (or refinancings thereof); 

(g) acquire or dispose of assets or a business, in each case for consideration in excess of $100,000,000; 

(h) terminate the employment of the Chief Executive Officer, other than for Cause (as defined in the employment agreement of the Chief
Executive Officer), in which case the Company shall consult in good faith with Taylor Parent on a replacement for the Chief Executive Officer; or. 

(i) adopt a stockholder rights plan that does not exempt as “grandfathered persons” the Stockholders and their Related Persons from
being deemed “acquiring persons” due to their Beneficial Ownership of Common Stock upon the public announcement of the adoption of such stockholder rights plan (it being understood that no such plan shall restrict any Stockholder or their
Related Persons from acquiring, in the aggregate, Common Stock up to the level of their aggregate percentage Beneficial Ownership as of the public announcement of the adoption of such stockholder rights plan). 

(j) This Section 6 shall terminate upon a Company Termination Event. 

Section 7. Representations and Warranties. 

(a) The Company hereby represents and warrants to the other parties hereto as follows: 

(i) The Company is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of
Delaware and has the corporate power and authority to own, lease and operate its properties and assets and to carry on its business as now being conducted. 

(ii) The Company has the power and authority to execute and deliver this Agreement and to perform its obligations hereunder.
This Agreement has been duly authorized, executed and delivered by the Company and, when duly executed by the other parties hereto and delivered by such parties, shall constitute the legal, valid and binding obligations of the Company, enforceable
against the Company, in accordance with its terms, subject to Enforceability Exceptions. 
 (iii) The execution, delivery and
performance of this Agreement by the Company will not (a) conflict with or result in any breach of any provision of the Organizational Documents of the Company, (b) require any filing with, or the obtaining of any permit, authorization,
consent or approval of, any Governmental Authority, (c) violate, conflict with or result in a default (or any event which, with notice or lapse of time or both, would constitute a default) under, or give rise to any right of termination,
cancellation or acceleration under, any of the terms, conditions or provisions of any note, mortgage, other evidence of indebtedness, guarantee, license, agreement, lease or other contract, instrument or obligation to which the Company or any of its
assets may be bound, (d) violate any Law applicable to the Company or (e), result in the creation or imposition of any Lien upon or with respect to any of the assets owned, leased or licensed by the Company, excluding from the foregoing clauses
(b), (c), (d) and (e) such requirements, violations, conflicts, defaults or rights which would not, or would not be reasonably likely to, have a material and adverse effect on the Company. 

(b) Taylor Parent and each other Stockholder who becomes a party to this Agreement after the date hereof, hereby represents and warrants to
the Company as follows: 
 (i) Such party is a corporation duly organized, validly existing and in good standing under the
Laws of its jurisdiction of formation and has the corporate power and authority to own, lease and operate its properties and assets and to carry on its business as now being conducted. 

  
 21 

 (ii) Such party has the power and authority to execute and deliver this Agreement
and to perform its obligations hereunder. This Agreement has been duly authorized, executed and delivered by such party and, when duly executed by the other parties hereto and delivered by such parties, shall constitute the legal, valid and binding
obligations of such party, enforceable against such party, in accordance with its terms, subject to Enforceability Exceptions. 

(iii) The execution, delivery and performance of this Agreement by such party will not (a) conflict with or result in any
breach of any provision of the Organizational Documents of such party, (b) require any filing with, or the obtaining of any permit, authorization, consent or approval of, any Governmental Authority, (c) violate, conflict with or result in
a default (or any event which, with notice or lapse of time or both, would constitute a default) under, or give rise to any right of termination, cancellation or acceleration under, any of the terms, conditions or provisions of any note, mortgage,
other evidence of indebtedness, guarantee, license, agreement, lease or other contract, instrument or obligation to which such party or any of its assets may be bound, (d) violate any Law applicable to such party or (e), result in the creation
or imposition of any Lien upon or with respect to any of the assets owned, leased or licensed by such party, excluding from the foregoing clauses (b), (c), (d) and (e) such requirements, violations, conflicts, defaults or rights which would
not, or would not be reasonably likely to, have a material and adverse effect on such party. 
 (iv) Such party, when taken
together with the other Stockholders and their Affiliates, has the ability to cause the Centre Partner Funds to take, or refrain from taking, the applicable actions as set forth herein. 

Section 8. Miscellaneous. 

(a) Term. This Agreement shall be effective upon the Closing and shall continue in effect until 11:59 p.m., New York City time, on the
date that Taylor Parent and its Permitted Transferees cease to Beneficially Own any Restricted Shares. 
 (b) Confidentiality. 

(i) Each of Taylor Parent and each Stockholder agrees, and will require each of its Representatives including each Taylor
Parent Designee to agree, to hold in confidence and not use or disclose to any third party any non-public information provided by the Company or its Representatives to such Person in connection with its direct
or indirect investment in the Company or the exercise of such Person’s rights under this Agreement (the “Confidential Information”); provided, however, “Confidential Information” does not include
information or data that: (i) is or was independently developed by such Person or its Representatives without breaching this Agreement; (ii) was or is publicly available prior to the Effective Date or is or subsequently becomes publicly
available other than as a result of a disclosure by such Person in breach of this Agreement; (iii) is or becomes available to such Person or its Representatives from a source other than the Company, provided that the source of such information
was not known by such Person to be bound by a confidentiality agreement with, or other contractual, legal or fiduciary obligation of confidentiality to, the Company or any other party with respect to such information; or (iv) was already in the
possession of such Person or its Representatives at the time disclosed by the Company to such Person, provided that the source of such information was not known by such Person to be bound by a confidentiality agreement with, or other contractual,
legal or fiduciary obligation of confidentiality to, the Company or any other party with respect to such information. 
 (ii)
Notwithstanding the foregoing, in the event that any of Taylor Parent, Centre Partners (or any Centre Partners Fund) or any Stockholder or any of their respective Representatives are required by Law or legal or judicial process (including without
limitation, by deposition, interrogatory, request for documents, subpoena, civil investigative demand or similar process) to disclose any of the Confidential Information, each such party may disclose such Confidential Information, and only the
portion of such Confidential Information, that, based on an opinion of such party’s counsel, is required by Law to be 

  
 22 

 
disclosed, but only after providing the Company, to the extent practicable and not prohibited by Law, with prompt prior written notice to the Company so that the Company may seek to limit or
eliminate such disclosure, including through the procurement of a protective order or other judicial remedy. Prior to disclosure of any Confidential Information in accordance with the preceding sentence, such party shall, at the Company’s
request and sole expense, use commercially reasonable efforts to provide such cooperation to the Company as the Company shall reasonably request in order to limit or eliminate disclosure of any Confidential Information and shall, at the
Company’s request and sole expense, use commercially reasonable efforts to obtain assurances from the Persons to whom such confidential information is disclosed that such Persons will afford such information confidential treatment. 

(iii) Nothing in this Agreement, including Section 8(b)(i), shall limit or restrict any Taylor Parent Designee in acting
in his or her capacity as a director of Buyer and exercising his or her fiduciary duties and responsibilities. 
 (c) Notices. All
notices, requests, consents and other communications hereunder to any party hereto shall be deemed to be sufficient if contained in a written instrument and shall be deemed to have been duly given when delivered in person, by telecopy, by
nationally-recognized overnight courier, or by first class registered or certified mail, postage prepaid, addressed to such party at the address set forth below or such other address as may hereafter be designated in writing by the addressee to the
addressor: 
 Lifetime Brands, Inc. 

1000 Stewart Avenue 
 Garden
City, NY 11530 
 Attention:     Sara A. Shindel, General Counsel & Secretary 

Facsimile:    (516) 450-0009 

with a copy to (which notice shall not constitute notice to the Company): 

Morgan, Lewis & Bockius LLP 

101 Park Avenue 
 New York, NY
10178 
 Attention:     David W. Pollak & Andrew Milano 

Facsimile:    (212) 309-6001 

if to Taylor Parent to: 
 Taylor
Parent, LLC 
 c/o Centre Partners Management LLC 

825 Third Avenue, 40th Floor 

New York, NY 10022 

Attention:     Bruce Pollack & Michael Schnabel 

Facsimile:    (212) 758-1830 

with a copy to (which notice shall not constitute notice to Taylor Parent): 

Paul, Weiss, Rifkind, Wharton & Garrison LLP 

1285 Avenue of the Americas 

New York, New York 10019-6064 

Attention:     Steven J. Williams, Esq. 

Facsimile:    (212) 757-3990 

If to any other Stockholder, to the address on record with the Company. 

  
 23 

 All such notices, requests, consents and other communications shall be deemed to have been delivered (a) in
the case of personal delivery or delivery by telecopy, on the date of such delivery, (b) in the case of nationally-recognized overnight courier, on the next Business Day and (c) in the case of mailing, on the third Business Day following
such mailing if sent by certified mail, return receipt requested. 
 (d) Entire Agreement. This Agreement, the Escrow Agreement, the
Voting Agreement, the Merger Agreement and the other documents delivered at the Closing pursuant hereto or thereto (including the Exhibits and Schedules attached hereto and thereto), contain the entire understanding of the Parties in respect of
their subject matter and supersede all prior agreements and understandings (oral or written) between the Parties with respect to such subject matter, other than the Confidentiality Agreement, which shall survive in full force and effect. 

(e) Expenses. Except as otherwise expressly provided in Section 2(j), the Parties shall pay their own fees
and expenses, including their own counsel fees, incurred in connection with this Agreement. 
 (f) Amendment; Waiver. This Agreement
may not be modified, amended, supplemented, canceled or discharged, except by written instrument executed by the Company and Taylor Parent (or its Permitted Transferees). No failure to exercise, and no delay in exercising, any right, power or
privilege under this Agreement shall operate as a waiver, nor shall any single or partial exercise of any right, power or privilege hereunder preclude the exercise of any other right, power or privilege. 

(g) Binding Effect; Assignment. The rights and obligations of this Agreement shall bind and inure to the benefit of the parties hereto
and their respective successors and assigns. Except as expressly provided herein, the rights and obligations of this Agreement may not be assigned by the parties hereto without the prior written consent of the other parties hereto. 

(h) Counterparts. This Agreement may be executed in any number of counterparts (including by means of facsimile and electronically
transmitted portable document format (pdf) signature pages), each of which shall be an original but all of which together shall constitute one and the same instrument. 

(i) Interpretation; Schedules. 

(i) Unless the context of this Agreement otherwise clearly requires, (i) references to the plural include the singular, and references to
the singular include the plural, (ii) references to one gender include the other gender, (iii) the words “include”, “includes” and “including” do not limit the preceding terms or words and shall be deemed to
be followed by the words “without limitation” or “but not limited to”, (iv) the terms “hereof”, “herein”, “hereunder”, “hereto” and similar terms in this Agreement refer to this
Agreement as a whole and not to any particular provision of this Agreement, (v) the terms “day” and “days” mean and refer to calendar day(s), (vi) the terms “year” and “years” mean and refer to
calendar year(s), and (vii) all references to “$” in this Agreement shall be deemed references to United States dollars. 

(ii) Unless otherwise set forth in this Agreement, references in this Agreement to (i) any document, instrument or agreement (including
this Agreement) (A) includes and incorporates all Exhibits, Schedules and other attachments thereto, (B) includes all documents, instruments or agreements issued or executed in replacement thereof and (C) means such document,
instrument or agreement, or replacement or predecessor thereto, as amended, modified or supplemented from time to time in accordance with its terms and in effect at any given time, and (ii) a particular Law means such Law, as amended, modified,
supplemented or succeeded from time to time. All Article, Section, Exhibit and Schedule references herein are to Articles, Sections, Exhibits and Schedules of this Agreement, unless otherwise specified. 

(iii) The headings contained herein, and on the Schedules are for reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement or the Schedules. 

  
 24 

 (iv) This Agreement shall not be construed as if prepared by one of the parties hereto, but
rather according to its fair meaning as a whole, as if all parties hereto had prepared it. 
 (j) Governing Law; Interpretation. THIS
AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE WITHOUT GIVING EFFECT TO ANY CHOICE OR CONFLICT OF LAW PROVISION (WHETHER OF THE STATE OF DELAWARE OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE
APPLICATION OF THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF DELAWARE. 
 (k) Forum Selection and Consent to Jurisdiction; Waiver
of Jury Trial. 
 (i) EACH PARTY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF (A) COURT OF CHANCERY OF THE STATE OF
DELAWARE AND (B) ANY UNITED STATES DISTRICT COURT FOR THE STATE OF DELAWARE (FOR THE PURPOSES OF ANY SUIT, ACTION OR OTHER PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR THE NEGOTIATION, EXECUTION, PERFORMANCE OR ENFORCEMENT OF
THIS AGREEMENT OR ANY TRANSACTIONS CONTEMPLATED HEREBY AND AGREES THAT ALL CLAIMS IN RESPECT OF THE SUIT, ACTION OR OTHER PROCEEDING MAY BE HEARD AND DETERMINED IN ANY SUCH COURT. EACH PARTY HERETO AGREES TO COMMENCE ANY SUCH SUIT, ACTION OR OTHER
PROCEEDING EITHER IN ANY UNITED STATES DISTRICT COURT FOR THE STATE OF DELAWARE OR IN THE COURT OF CHANCERY FOR THE STATE OF DELAWARE. EACH PARTY HERETO WAIVES ANY DEFENSE OF IMPROPER VENUE OR INCONVENIENT FORUM TO THE MAINTENANCE OF ANY ACTION OR
PROCEEDING SO BROUGHT AND WAIVES ANY BOND, SURETY, OR OTHER SECURITY THAT MIGHT BE REQUIRED OF ANY OTHER PARTY WITH RESPECT THERETO. ANY PARTY HERETO MAY MAKE SERVICE ON ANY OTHER PARTY BY SENDING OR DELIVERING A COPY OF THE PROCESS TO THE PARTY TO
BE SERVED AT THE ADDRESS AND IN THE MANNER PROVIDED FOR THE GIVING OF NOTICES IN SECTION 8(c), HOWEVER, SHALL AFFECT THE RIGHT OF ANY PARTY TO SERVE LEGAL PROCESS IN ANY OTHER MANNER PERMITTED BY LAW OR AT EQUITY. EACH PARTY AGREES THAT A
FINAL JUDGMENT IN ANY ACTION OR PROCEEDING SO BROUGHT SHALL BE CONCLUSIVE AND MAY BE ENFORCED BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW OR AT EQUITY. 

(ii) EACH OF THE PARTIES HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE HEREUNDER IS LIKELY TO INVOLVE COMPLICATED AND
DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY HEREBY WAIVES ITS RIGHT TO A JURY TRIAL WITH RESPECT TO ANY ACTION OR CLAIM ARISING OUT OF ANY DISPUTE IN CONNECTION WITH THIS AGREEMENT, ANY RIGHTS OR OBLIGATIONS HEREUNDER OR THE PERFORMANCE OF SUCH
RIGHTS AND OBLIGATIONS. EACH OF THE PARTIES HERETO (I) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HERETO HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY HERETO WOULD NOT, IN THE EVENT OF LITIGATION,
SEEK TO ENFORCE THE FOREGOING WAIVERS AND (II) UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (III) MAKES THIS WAIVER VOLUNTARILY, AND (IV) ACKNOWLEDGES THAT SUCH OTHER PARTY HAS BEEN INDUCED TO ENTER INTO THIS
AGREEMENT BY, AMONG OTHER THINGS, THE WAIVERS AND CERTIFICATIONS CONTAINED HEREIN. 
 (l) Specific Performance. 

(i) The parties hereto agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the
terms hereof, that any breach of this Agreement would not be adequately compensated by monetary damages and that, accordingly, the parties hereto shall be entitled to specific performance of the terms hereof, in addition to any other remedy to which
they are entitled at Law or in 

  
 25 

 
equity. Each party hereto hereby agrees not to raise any objections to the availability of the equitable remedy of specific performance when available pursuant to the terms of this Agreement to
prevent or restrain breaches of this Agreement by such party and to specifically enforce the terms and provisions of this Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants and agreements of such
party under this Agreement in accordance with the terms of this Section 8(l). The parties hereto further agree to waive any requirement for the securing or posting of any bond in connection with the obtaining of any
specific performance or other equitable relief, this being in addition to any other remedy to which they are entitled at Law or in equity. The parties hereto have specifically bargained for the right to specific performance of the obligations
hereunder, in accordance with the terms and conditions of this Section 8(l). 
 (ii) All remedies hereunder are
cumulative and are not exclusive of any other remedies provided by law or equity. Each party hereto further agrees that (A) by seeking the remedies provided for in this Section 8(l), a party shall not in any respect
waive its right to seek any other form of relief that may be available to such party under this Agreement or in the event that the remedies provided for in this Section 8(l) are not available or otherwise are not granted,
and (B) the commencement of any Proceeding pursuant to this Section 8(l) or anything set forth in this Section 8(l) restrict or limit any party’s right to pursue any other remedies under
this Agreement that may be available then or thereafter. 
 (iii) Each party hereto further agrees that the only permitted objection that
it may raise in response to any action for equitable relief is that it contests the existence of a breach or threatened breach of this Agreement. 

(m) Time. With regard to all dates and time periods set forth or referred to in this Agreement, time is of the essence. 

(n) Third Party Beneficiaries. Except as otherwise specifically set forth herein, no provision of this Agreement is intended to confer
upon any Person other than the parties hereto any rights or remedies, legal or equitable, hereunder, and no other Person other than the parties hereto shall be entitled to rely thereon.  

(o) Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of
Law or public policy, all other terms, conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated by this Agreement is not affected in
any manner materially adverse to any party hereto. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect
the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated by this Agreement be consummated as originally contemplated to the fullest extent possible. 

(p) Assurances of Performance. Each of the Stockholders shall use its commercially reasonable efforts to cause its respective Related
Persons to comply with the terms of this Agreement applicable thereto (it being understood that such Stockholder shall be responsible to the Company for any breach of such terms by any such Related Person). 

[Signature Page Follows] 

  
 26 

 IN WITNESS WHEREOF, the duly authorized representative of the parties hereto has caused
this Stockholders Agreement to be duly executed and delivered as of the day and year first above written. 
  

			
	LIFETIME BRANDS, INC.
		
	By:	 	  

		 	Name:
		 	Title:
	
	TAYLOR PARENT, LLC
		
	By:	 	  

		 	Name:
		 	Title:

 Signature Page to Stockholders Agreement 

 Schedule I 

[To be updated from time to time.] 

 EXHIBIT A 

Fully Diluted Basis 

  
 2 

 EXHIBIT B 

Form of Irrevocable Resignation 

Lifetime Brands, Inc. 
 Attention: Board of Directors 

1000 Stewart Avenue 
 Garden City, NY 11530 

Ladies and Gentlemen: 
 I refer to the Stockholders Agreement,
dated as of [●], 2018, as it may be amended from time to time by and among Lifetime Brands, Inc., a Delaware corporation (the “Company”), Taylor Parent, LLC, a Delaware limited liability company, and the other parties thereto
(the “Stockholders Rights Agreement”). Capitalized terms used but not defined in this letter have the meanings set forth in the Agreement. 

This letter is to confirm that, in accordance with Section 5(b) of the Stockholders Rights Agreement, I hereby irrevocably tender my resignation
as a member of the Board of Directors of the Company (the “Board”) and each committee of the Board on which I serve, it being understood that (i) this advance letter of resignation shall be effective at such time, and subject
to the conditions provided for in Section 5(b) of the Stockholders Rights Agreement, and (ii) this advance letter of resignation shall be effective only as, if and when accepted by the Board. 

I understand and acknowledge that this advance letter of resignation from the Board is irrevocable and may not be withdrawn by me at any time. 

Sincerely, 
 [NAME OF DIRECTOR] 

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}]]